<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="jciinsight" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC5499370/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499370/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="JCI Insight" /><meta name="citation_title" content="Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin" /><meta name="citation_authors" content="Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, Michal Pawlak, Céline Gheeraert, Hélène Dehondt, Jonathan Vanhoutte, Eloise Woitrain, Nathalie Hennuyer, Claire Mazuy, Marie Bobowski-Gérard, Francesco Paolo Zummo, Bruno Derudas, Ann Driessen, Guy Hubens, Luisa Vonghia, Wilhelmus J. Kwanten, Peter Michielsen, Thomas Vanwolleghem, Jérôme Eeckhoute, An Verrijken, Luc Van Gaal, Sven Francque, Bart Staels" /><meta name="citation_date" content="6 July 2017" /><meta name="citation_issue" content="13" /><meta name="citation_volume" content="2" /><meta name="citation_doi" content="10.1172/jci.insight.92264" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5499370/?report=abstract" /><meta name="citation_pmid" content="28679947" /><meta name="DC.Title" content="Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="American Society for Clinical Investigation" /><meta name="DC.Contributor" content="Philippe Lefebvre" /><meta name="DC.Contributor" content="Fanny Lalloyer" /><meta name="DC.Contributor" content="Eric Baugé" /><meta name="DC.Contributor" content="Michal Pawlak" /><meta name="DC.Contributor" content="Céline Gheeraert" /><meta name="DC.Contributor" content="Hélène Dehondt" /><meta name="DC.Contributor" content="Jonathan Vanhoutte" /><meta name="DC.Contributor" content="Eloise Woitrain" /><meta name="DC.Contributor" content="Nathalie Hennuyer" /><meta name="DC.Contributor" content="Claire Mazuy" /><meta name="DC.Contributor" content="Marie Bobowski-Gérard" /><meta name="DC.Contributor" content="Francesco Paolo Zummo" /><meta name="DC.Contributor" content="Bruno Derudas" /><meta name="DC.Contributor" content="Ann Driessen" /><meta name="DC.Contributor" content="Guy Hubens" /><meta name="DC.Contributor" content="Luisa Vonghia" /><meta name="DC.Contributor" content="Wilhelmus J. Kwanten" /><meta name="DC.Contributor" content="Peter Michielsen" /><meta name="DC.Contributor" content="Thomas Vanwolleghem" /><meta name="DC.Contributor" content="Jérôme Eeckhoute" /><meta name="DC.Contributor" content="An Verrijken" /><meta name="DC.Contributor" content="Luc Van Gaal" /><meta name="DC.Contributor" content="Sven Francque" /><meta name="DC.Contributor" content="Bart Staels" /><meta name="DC.Date" content="2017 Jul 6" /><meta name="DC.Identifier" content="10.1172/jci.insight.92264" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin" /><meta property="og:type" content="article" /><meta property="og:description" content="Nonalcoholic fatty liver disease prevalence is soaring with the obesity pandemic, but the pathogenic mechanisms leading to the progression toward active nonalcoholic steatohepatitis (NASH) and fibrosis, major causes of liver-related death, are poorly ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499370/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jciinsight.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5499370/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5499370/pdf/jciinsight-2-92264.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FB49BFB4D38EC10000000000820081.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/3101/">JCI Insight</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/294930/">v.2(13); 2017 Jul 6</a></li><li class="accid">PMC5499370</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jciinsight.gif" alt="Logo of jciinsight" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,75" alt="JCI Insight" title="JCI Insight" href="https://insight.jci.org/" ref="reftype=publisher&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">JCI Insight</span>. 2017 Jul 6; 2(13): e92264. </span></div><div><span class="fm-vol-iss-date">Published online 2017 Jul 6. </span>  <span class="doi">doi:  <a href="//dx.doi.org/10.1172%2Fjci.insight.92264" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1172/jci.insight.92264</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5499370</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/28679947">28679947</a></div></div></div></div></div><h1 class="content-title">Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPAR<strong>&#x003b1;</strong>-regulated dermatopontin</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Lefebvre%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116597146208" co-class="co-affbox">Philippe Lefebvre</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="/pubmed/?term=Lalloyer%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116630960608" co-class="co-affbox">Fanny Lalloyer</a>,<sup>1</sup> <a href="/pubmed/?term=Baug%26%23x000e9%3B%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116559426096" co-class="co-affbox">Eric Baug&#x000e9;</a>,<sup>1</sup> <a href="/pubmed/?term=Pawlak%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561239280" co-class="co-affbox">Michal Pawlak</a>,<sup>1</sup> <a href="/pubmed/?term=Gheeraert%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561237040" co-class="co-affbox">C&#x000e9;line Gheeraert</a>,<sup>1</sup> <a href="/pubmed/?term=Dehondt%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561234800" co-class="co-affbox">H&#x000e9;l&#x000e8;ne Dehondt</a>,<sup>1</sup> <a href="/pubmed/?term=Vanhoutte%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561232560" co-class="co-affbox">Jonathan Vanhoutte</a>,<sup>1</sup> <a href="/pubmed/?term=Woitrain%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561230320" co-class="co-affbox">Eloise Woitrain</a>,<sup>1</sup> <a href="/pubmed/?term=Hennuyer%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561228080" co-class="co-affbox">Nathalie Hennuyer</a>,<sup>1</sup> <a href="/pubmed/?term=Mazuy%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561225840" co-class="co-affbox">Claire Mazuy</a>,<sup>1</sup> <a href="/pubmed/?term=Bobowski-G%26%23x000e9%3Brard%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561223600" co-class="co-affbox">Marie Bobowski-G&#x000e9;rard</a>,<sup>1</sup> <a href="/pubmed/?term=Zummo%20FP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561221616" co-class="co-affbox">Francesco Paolo Zummo</a>,<sup>1</sup> <a href="/pubmed/?term=Derudas%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561219376" co-class="co-affbox">Bruno Derudas</a>,<sup>1</sup> <a href="/pubmed/?term=Driessen%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116561217136" co-class="co-affbox">Ann Driessen</a>,<sup>2</sup> <a href="/pubmed/?term=Hubens%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554602896" co-class="co-affbox">Guy Hubens</a>,<sup>3</sup> <a href="/pubmed/?term=Vonghia%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554600656" co-class="co-affbox">Luisa Vonghia</a>,<sup>4,</sup><sup>5</sup> <a href="/pubmed/?term=Kwanten%20WJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554596944" co-class="co-affbox">Wilhelmus J. Kwanten</a>,<sup>4,</sup><sup>6</sup> <a href="/pubmed/?term=Michielsen%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554594224" co-class="co-affbox">Peter Michielsen</a>,<sup>4,</sup><sup>6</sup> <a href="/pubmed/?term=Vanwolleghem%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554590512" co-class="co-affbox">Thomas Vanwolleghem</a>,<sup>4,</sup><sup>6</sup> <a href="/pubmed/?term=Eeckhoute%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554586800" co-class="co-affbox">J&#x000e9;r&#x000f4;me Eeckhoute</a>,<sup>1</sup> <a href="/pubmed/?term=Verrijken%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554584560" co-class="co-affbox">An Verrijken</a>,<sup>5,</sup><sup>6</sup> <a href="/pubmed/?term=Van%20Gaal%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116554581584" co-class="co-affbox">Luc Van Gaal</a>,<sup>5,</sup><sup>6</sup> <a href="/pubmed/?term=Francque%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116628878336" co-class="co-affbox">Sven Francque</a>,<sup>4,</sup><sup>6</sup> and  <a href="/pubmed/?term=Staels%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947" class="affpopup" co-rid="_co_idm140116628874624" co-class="co-affbox">Bart Staels</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140116597146208"><h3 class="no_margin">Philippe Lefebvre</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Lefebvre%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Philippe Lefebvre</a></div></div><div id="_co_idm140116630960608"><h3 class="no_margin">Fanny Lalloyer</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Lalloyer%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Fanny Lalloyer</a></div></div><div id="_co_idm140116559426096"><h3 class="no_margin">Eric Baug&#x000e9;</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Baug%26%23x000e9%3B%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Eric Baug&#x000e9;</a></div></div><div id="_co_idm140116561239280"><h3 class="no_margin">Michal Pawlak</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Pawlak%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Michal Pawlak</a></div></div><div id="_co_idm140116561237040"><h3 class="no_margin">C&#x000e9;line Gheeraert</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Gheeraert%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">C&#x000e9;line Gheeraert</a></div></div><div id="_co_idm140116561234800"><h3 class="no_margin">H&#x000e9;l&#x000e8;ne Dehondt</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Dehondt%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">H&#x000e9;l&#x000e8;ne Dehondt</a></div></div><div id="_co_idm140116561232560"><h3 class="no_margin">Jonathan Vanhoutte</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Vanhoutte%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Jonathan Vanhoutte</a></div></div><div id="_co_idm140116561230320"><h3 class="no_margin">Eloise Woitrain</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Woitrain%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Eloise Woitrain</a></div></div><div id="_co_idm140116561228080"><h3 class="no_margin">Nathalie Hennuyer</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Hennuyer%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Nathalie Hennuyer</a></div></div><div id="_co_idm140116561225840"><h3 class="no_margin">Claire Mazuy</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Mazuy%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Claire Mazuy</a></div></div><div id="_co_idm140116561223600"><h3 class="no_margin">Marie Bobowski-G&#x000e9;rard</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Bobowski-G%26%23x000e9%3Brard%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Marie Bobowski-G&#x000e9;rard</a></div></div><div id="_co_idm140116561221616"><h3 class="no_margin">Francesco Paolo Zummo</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Zummo%20FP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Francesco Paolo Zummo</a></div></div><div id="_co_idm140116561219376"><h3 class="no_margin">Bruno Derudas</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Derudas%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Bruno Derudas</a></div></div><div id="_co_idm140116561217136"><h3 class="no_margin">Ann Driessen</h3><p><sup>2</sup>Department of Pathology,</p><div>Find articles by <a href="/pubmed/?term=Driessen%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Ann Driessen</a></div></div><div id="_co_idm140116554602896"><h3 class="no_margin">Guy Hubens</h3><p><sup>3</sup>Department of Abdominal Surgery,</p><div>Find articles by <a href="/pubmed/?term=Hubens%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Guy Hubens</a></div></div><div id="_co_idm140116554600656"><h3 class="no_margin">Luisa Vonghia</h3><p><sup>4</sup>Department of Gastroenterology and Hepatology, and</p><p><sup>5</sup>Department of Endocrinology, Diabetology and Metabolism, University Hospital Antwerp, Edegem, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Vonghia%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Luisa Vonghia</a></div></div><div id="_co_idm140116554596944"><h3 class="no_margin">Wilhelmus J. Kwanten</h3><p><sup>4</sup>Department of Gastroenterology and Hepatology, and</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Kwanten%20WJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Wilhelmus J. Kwanten</a></div></div><div id="_co_idm140116554594224"><h3 class="no_margin">Peter Michielsen</h3><p><sup>4</sup>Department of Gastroenterology and Hepatology, and</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Michielsen%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Peter Michielsen</a></div></div><div id="_co_idm140116554590512"><h3 class="no_margin">Thomas Vanwolleghem</h3><p><sup>4</sup>Department of Gastroenterology and Hepatology, and</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Vanwolleghem%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Thomas Vanwolleghem</a></div></div><div id="_co_idm140116554586800"><h3 class="no_margin">J&#x000e9;r&#x000f4;me Eeckhoute</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Eeckhoute%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">J&#x000e9;r&#x000f4;me Eeckhoute</a></div></div><div id="_co_idm140116554584560"><h3 class="no_margin">An Verrijken</h3><p><sup>5</sup>Department of Endocrinology, Diabetology and Metabolism, University Hospital Antwerp, Edegem, Belgium.</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Verrijken%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">An Verrijken</a></div></div><div id="_co_idm140116554581584"><h3 class="no_margin">Luc Van Gaal</h3><p><sup>5</sup>Department of Endocrinology, Diabetology and Metabolism, University Hospital Antwerp, Edegem, Belgium.</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Van%20Gaal%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Luc Van Gaal</a></div></div><div id="_co_idm140116628878336"><h3 class="no_margin">Sven Francque</h3><p><sup>4</sup>Department of Gastroenterology and Hepatology, and</p><p><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</p><div>Find articles by <a href="/pubmed/?term=Francque%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Sven Francque</a></div></div><div id="_co_idm140116628874624"><h3 class="no_margin">Bart Staels</h3><p><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</p><div>Find articles by <a href="/pubmed/?term=Staels%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28679947">Bart Staels</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140116560001296_ai" style="display:none"><div class="fm-affl" lang="en" id="A1"><sup>1</sup>University Lille, Inserm, CHU-Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.</div><div class="fm-affl" lang="en" id="A2"><sup>2</sup>Department of Pathology,</div><div class="fm-affl" lang="en" id="A3"><sup>3</sup>Department of Abdominal Surgery,</div><div class="fm-affl" lang="en" id="A4"><sup>4</sup>Department of Gastroenterology and Hepatology, and</div><div class="fm-affl" lang="en" id="A5"><sup>5</sup>Department of Endocrinology, Diabetology and Metabolism, University Hospital Antwerp, Edegem, Belgium.</div><div class="fm-affl" lang="en" id="A6"><sup>6</sup>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="idm140116597146208">Philippe Lefebvre: <a href="mailto:dev@null" data-email="rf.mresni@ervbefel.edualc-eppilihp" class="oemail">rf.mresni@ervbefel.edualc-eppilihp</a>; </span> <span class="contrib-email" id="idm140116630960608">Fanny Lalloyer: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@reyollal.ynnaf" class="oemail">rf.ellil-ruetsap@reyollal.ynnaf</a>; </span> <span class="contrib-email" id="idm140116559426096">Eric Baug&#x000e9;: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@eguab.cire" class="oemail">rf.ellil-ruetsap@eguab.cire</a>; </span> <span class="contrib-email" id="idm140116561239280">Michal Pawlak: <a href="mailto:dev@null" data-email="lp.vog.bcmii@kalwapm" class="oemail">lp.vog.bcmii@kalwapm</a>; </span> <span class="contrib-email" id="idm140116561237040">C&#x000e9;line Gheeraert: <a href="mailto:dev@null" data-email="rf.mresni@treareehg.enilec" class="oemail">rf.mresni@treareehg.enilec</a>; </span> <span class="contrib-email" id="idm140116561234800">H&#x000e9;l&#x000e8;ne Dehondt: <a href="mailto:dev@null" data-email="rf.2ellil-vinu@tdnohed.eneleh" class="oemail">rf.2ellil-vinu@tdnohed.eneleh</a>; </span> <span class="contrib-email" id="idm140116561232560">Jonathan Vanhoutte: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@ettuohnav.nahtanoj" class="oemail">rf.ellil-ruetsap@ettuohnav.nahtanoj</a>; </span> <span class="contrib-email" id="idm140116561230320">Eloise Woitrain: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@niartiow.esiole" class="oemail">rf.ellil-ruetsap@niartiow.esiole</a>; </span> <span class="contrib-email" id="idm140116561228080">Nathalie Hennuyer: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@reyunneh.eilahtan" class="oemail">rf.ellil-ruetsap@reyunneh.eilahtan</a>; </span> <span class="contrib-email" id="idm140116561225840">Claire Mazuy: <a href="mailto:dev@null" data-email="moc.liamg@88erialc.yuzam" class="oemail">moc.liamg@88erialc.yuzam</a>; </span> <span class="contrib-email" id="idm140116561221616">Francesco Paolo Zummo: <a href="mailto:dev@null" data-email="rf.mresni@ommuz.ocsecnarf" class="oemail">rf.mresni@ommuz.ocsecnarf</a>; </span> <span class="contrib-email" id="idm140116561219376">Bruno Derudas: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@sadured.onurb" class="oemail">rf.ellil-ruetsap@sadured.onurb</a>; </span> <span class="contrib-email" id="idm140116561217136">Ann Driessen: <a href="mailto:dev@null" data-email="eb.azu@nesseird.nna" class="oemail">eb.azu@nesseird.nna</a>; </span> <span class="contrib-email" id="idm140116554602896">Guy Hubens: <a href="mailto:dev@null" data-email="eb.azu@snebuH.yuG" class="oemail">eb.azu@snebuH.yuG</a>; </span> <span class="contrib-email" id="idm140116554600656">Luisa Vonghia: <a href="mailto:dev@null" data-email="eb.azu@aihgnov.asiul" class="oemail">eb.azu@aihgnov.asiul</a>; </span> <span class="contrib-email" id="idm140116554594224">Peter Michielsen: <a href="mailto:dev@null" data-email="eb.azu@nesleihcim.retep" class="oemail">eb.azu@nesleihcim.retep</a>; </span> <span class="contrib-email" id="idm140116554590512">Thomas Vanwolleghem: <a href="mailto:dev@null" data-email="eb.azu@mehgellownav.samoht" class="oemail">eb.azu@mehgellownav.samoht</a>; </span> <span class="contrib-email" id="idm140116554586800">J&#x000e9;r&#x000f4;me Eeckhoute: <a href="mailto:dev@null" data-email="rf.mresni@etuohkcee.emorej" class="oemail">rf.mresni@etuohkcee.emorej</a>; </span> <span class="contrib-email" id="idm140116554584560">An Verrijken: <a href="mailto:dev@null" data-email="eb.azu@nekjirrev.na" class="oemail">eb.azu@nekjirrev.na</a>; </span> <span class="contrib-email" id="idm140116554581584">Luc Van Gaal: <a href="mailto:dev@null" data-email="eb.ca.au@laagnav.cul" class="oemail">eb.ca.au@laagnav.cul</a>; </span> <span class="contrib-email" id="idm140116628878336">Sven Francque: <a href="mailto:dev@null" data-email="eb.azu@euqcnarf.nevs" class="oemail">eb.azu@euqcnarf.nevs</a>; </span> <span class="contrib-email" id="idm140116628874624">Bart Staels: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@sleatS.traB" class="oemail">rf.ellil-ruetsap@sleatS.traB</a></span> </div><div id="idm140116628854368">Address correspondence to : Bart Staels, 1 rue du Pr Calmette, Institut Pasteur Lille, 59000 Lille, France. Phone: 33.320877388; Email: <a href="mailto:dev@null" data-email="rf.ellil-ruetsap@sleats.trab" class="oemail">rf.ellil-ruetsap@sleats.trab</a>. Or to: Philippe Lefebvre, Building J&#x00026;K, Boulevard du Pr Leclerc, 59000 Lille, France. Phone: 33.320974220; Email: <a href="mailto:dev@null" data-email="rf.mresni@ervbefel.edualc-eppilihp" class="oemail">rf.mresni@ervbefel.edualc-eppilihp</a>. Or to: Sven Francque, UZA, Wilrijkstraat 10, B-2650 Edegem, Belgium. Phone: 32.38214572; Email: <a href="mailto:dev@null" data-email="eb.azu@euqcnarF.nevs" class="oemail">eb.azu@euqcnarF.nevs</a>.</div><div id="idm140116553741952"><strong>Authorship note:</strong> SF and BS are co&#x02013;senior authors.</div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140116560001296_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140116560001296_an">Article notes <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140116560001296_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140116560001296_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2016 Dec 15; Accepted 2017 May 19.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140116560001296_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2017, American Society for Clinical Investigation</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>This article has been <a href="/pmc/articles/PMC5499370/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140116553731936" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140116553731936title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">Nonalcoholic fatty liver disease prevalence is soaring with the obesity pandemic, but the pathogenic mechanisms leading to the progression toward active nonalcoholic steatohepatitis (NASH) and fibrosis, major causes of liver-related death, are poorly defined. To identify key components during the progression toward NASH and fibrosis, we investigated the liver transcriptome in a human cohort of NASH patients. The transition from histologically proven fatty liver to NASH and fibrosis was characterized by gene expression patterns that successively reflected altered functions in metabolism, inflammation, and epithelial-mesenchymal transition. A meta-analysis combining our and public human transcriptomic datasets with murine models of NASH and fibrosis defined a molecular signature characterizing NASH and fibrosis and evidencing abnormal inflammation and extracellular matrix (ECM) homeostasis. Dermatopontin expression was found increased in fibrosis, and reversal of fibrosis after gastric bypass correlated with decreased dermatopontin expression. Functional studies in mice identified an active role for dermatopontin in collagen deposition and fibrosis. PPAR&#x003b1; activation lowered dermatopontin expression through a transrepressive mechanism affecting the Klf6/TGF&#x003b2;1 pathway. Liver fibrotic histological damages are thus characterized by the deregulated expression of a restricted set of inflammation- and ECM-related genes. Among them, dermatopontin may be a valuable target to reverse the hepatic fibrotic process.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Gastroenterology</span></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">Introduction</h2><p id="__p4" class="p p-first">Excessive, high-energy diets trigger a plethora of chronic pathologies, most of them remaining asymptomatic for many years until serious clinical complications occur. Among them, nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity and insulin resistance and predisposes patients to hepatic and extrahepatic disorders such as cirrhosis, type 2 diabetes, and cardiovascular diseases (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070565">1</a>). NAFLD encompasses a broad spectrum of liver histological alterations, ranging from simple steatosis (NAFL) to hepatocyte cell death (ballooning) and inflammation (nonalcoholic steatohepatitis [NASH]). Although not a prerequisite for diagnosis, fibrosis can also occur (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070518">2</a>) and is an indicator of liver-related mortality risk in NAFLD patients (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070585">3</a>).</p><p id="__p5">Highly related to wound-healing processes, fibrosis is the result of an exacerbated but reversible response leading to both qualitatively and quantitatively abnormal extracellular matrix (ECM) deposition (<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070572">4</a>). ECM homeostasis in the liver depends on the orchestrated interplay of hepatic stellate cells (HSCs) with other cells such as parenchymal and liver sinusoidal endothelial cells (LSECs), which regulate ECM deposition and resorption (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070556">5</a>). These processes are under the control of autocrine and paracrine signals, such as the TGF&#x003b2;, PDGF, connective tissue growth factor (CTGF), and Hippo pathways (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070512">6</a>, <a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070583">7</a>), and ensure optimal tissue functionality owing to the mechanical and biochemical properties of ECM. In NASH, iterative deleterious signals activate LSECs and HSCs (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070528">8</a>, <a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070596">9</a>), thereby compromising ECM component production and turnover. The ensuing fibrotic process functionally and structurally alters the intrahepatic vasculature, and a complex cascade of events can ultimately lead to cirrhosis and its complications, including increased death rates (<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070563">10</a>, <a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070555">11</a>). Active NASH with fibrosis is therefore a major risk factor in NAFLD-related morbidity and mortality.</p><p id="__p6">Loss of body weight improves the histological features of NAFLD (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070600">12</a>). This can be achieved by lifestyle modification, but most patients fail to reach the required goals to achieve reversal of the disease (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070606">12</a>). Bariatric surgery (BarSur) is the most effective procedure to induce sustained weight loss and triggers profound positive metabolic effects in obese and diabetic patients. It also is highly effective to reverse NASH and fibrosis in obese patients (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070586">13</a>&#x02013;<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070593">17</a>). Although there are no pharmacological options for the treatment of NASH or fibrosis, a few potentially valuable molecules are currently under clinical evaluation. For example, activation of the PPAR nuclear receptors in preclinical models protects from dietary-induced or genetically induced NASH and fibrosis (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070516">18</a>, <a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070573">19</a>). Assessment of the translation of such observations to human pathology is currently underway. These yet-unmet clinical needs therefore call for the identification of the protagonists of NASH and fibrosis.</p><p id="__p7">Mechanistic, preclinical, and clinical studies delineated molecular pathways contributing to the progression of NAFLD from NAFL to NASH and fibrosis (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070545">20</a>, <a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070554">21</a>). Gene profiling experiments in cross-sectional studies have proven useful in identifying factors involved in NAFLD progression. Performed on cohorts stratified on the basis of more or less refined histological parameters (alcoholic steatohepatitis and NASH vs. no NASH, NASH vs. no NASH, control vs. steatosis vs. NASH, control vs. steatosis vs. NASH with steatosis &#x0003e; 5% vs. NASH with steatosis &#x0003c; 5%; refs. <a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070560">22</a>&#x02013;<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070616">26</a>), these studies identified specific protagonists such as the Wnt pathway; genes involved in absorption, distribution, metabolism, and excretion (ADME); aldose reductase <em>AKR1B10</em>; and keratin family member <em>KRT23</em>. Comparing the liver transcriptome of NAFLD patients with no or little fibrosis to the one of fibrotic patients revealed genes involved in cellular proliferation and ECM organization (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070568">27</a>, <a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070594">28</a>).</p><p id="__p8" class="p p-last">Meta-analysis is a robust method to define disease molecular signatures and to identify potential biomarkers (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070525">29</a>). We therefore undertook a transcriptomic study of liver biopsies from 87 nondiabetic overweight/obese patients, which were metabolically and histologically phenotyped and represented all stages of NAFLD and fibrosis progression. A meta-analysis of our and publicly available datasets with comparable histological features was carried out to identify genes that are dysregulated in NASH and fibrosis. As gastric bypass (GABY) is most efficient to induce improvement of NAFLD, a paired analysis of the liver transcriptome before GABY and after a 1-year follow-up was used to identify genes whose expression is normalized by this surgical procedure, indicating their potential role in the pathophysiology of the disease and its resolution. Data were further crossed with transcriptomic data from NASH and fibrosis mouse models. Together with gene ontology (GO) classification, gene set enrichment analysis (GSEA), and other data-mining strategies, we identified a conserved set of genes, many of which associated to ECM homeostasis. Among them, dermatopontin (<em>DPT</em>) was upregulated in active NASH and fibrosis. It was further characterized since <em>Dpt</em> encodes a protein controlling skin collagen fibrillogenesis (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070546">30</a>) through interaction with fibronectin (<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070603">31</a>&#x02013;<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070598">33</a>), and it interacts with TGF&#x003b2; (<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070548">34</a>). <em>Dpt</em> expression was found to be necessary for collagen deposition in profibrotic conditions and was normalized by GABY in humans and by PPAR&#x003b1; activation in mice through a transrepression mechanism.</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title">Results</h2><div id="__sec3" class="sec sec-first"><h3>Transcriptomic analysis of liver biopsies from overweight patients with different degrees of NASH and fibrosis.</h3><p id="__p9" class="p p-first">Transcriptomic analysis of 87 liver biopsies from patients with distinct degrees of metabolic alterations, inflammation, and fibrosis (<a href="/pmc/articles/PMC5499370/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) was performed to identify transcripts coding for proteins that exhibit a &#x0003e; 20% differential expression level across samples, a threshold below which technical variation precludes reliable detection of gene expression variation. This defined a restricted set of 6,925 protein-encoding genes whose expression could be clustered through a self-organizing map (SOM) (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 1A</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 1</a>; supplemental material available online with this article; <a href="https://doi.org/10.1172/jci.insight.92264DS1" ref="reftype=extlink&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">https://doi.org/10.1172/jci.insight.92264DS1</a>). GO term enrichment of gene clusters pointed at pathways known to be altered in liver diseases (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 1B</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 1</a>), such as ECM deposition, immune response, regulation of transcription, and nuclear receptors, including the PPAR&#x003b1; pathway recently shown to be involved in liver inflammation and fibrosis in humans and rodents (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070511">35</a>, <a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070510">36</a>). However, this unsupervised learning&#x02013;based clustering strategy did not yield a clear-cut patient grouping according to biological or histological parameters, probably reflecting the diverse biological status of patients at the time of biopsy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Patient clinical and biochemical characteristics</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116554930352" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g007.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g007.jpg" /></a></div><div id="largeobj_idm140116554930352" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="__p10">Expressing hepatic gene expression variation as a function of quantified biological or histological parameters was therefore used as an alternative method. To do so, we analyzed, in a pair-wise manner, gene expression data from patients displaying no sign of alteration vs. those from patients with pronounced alteration of a given parameter (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 2</a>). This analysis was coupled to a GO term enrichment analysis to avoid any bias in selecting biological pathways emerging from the differential gene expression analysis. We first compared gene expression patterns of groups of patients with markedly different biometric (BMI) or systemic metabolic parameters (total cholesterol, triglycerides, homeostatic model assessment of insulin resistance (HOMA-IR). This analysis provided no evidence for a global alteration of genes involved in these systemic metabolic functions (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 2</a>), although a stratification based on BMI or HOMA-IR identified genes involved in lipid metabolism and reported to be dysregulated in NAFLD/NASH (<em>FASD1</em> and <em>FASD2</em>, <em>NR0B2</em> and <em>ELOVL2</em>; refs. <a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070625">22</a>, <a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070535">24</a>). In contrast, comparison of the liver transcriptomes from patients displaying different stages of hepatic histological damages with controls clearly identified functionally related clusters of genes. This approach was applied to steatosis, to the combination of lobular inflammation and ballooning, and to fibrosis. For example, a high fibrosis stage (F2&#x02013;4 vs. F0) correlated with an upregulated expression of genes involved in the immune response and ECM remodeling, including collagen fibril organization (<em>COL1A1</em>, <em>COL1A2</em>, <em>COL3A3</em>, <em>COL14A1</em>, <em>DPT</em>, <em>LUM</em>) and HSC activation (<em>TGFB1</em>) (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 3, A and B</a>; and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 2</a>). In contrast, repressed genes in fibrotic livers were related to metabolic processes (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 3B</a>). This comparative analysis for steatosis, for lobular inflammation and ballooning, and for fibrosis highlighted a progressive shift from metabolic disturbances in NAFL/steatosis to inflammatory responses in active NASH and ECM remodeling in fibrosis, evidenced by the altered expression of 251 genes in total (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116560878976" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g001.jpg" /></a></div><div id="largeobj_idm140116560878976" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Gene expression patterns in NAFLD and fibrosis progression and regression upon GABY.</strong><p id="__p59">(<strong>A</strong>) The cohort was stratified in 3 categories (nonalcoholic fatty liver, NAFL), nonalcoholic steatohepatitis (NASH) without fibrosis (NASH &#x02013; fibrosis), and NASH with fibrosis (NASH + fibrosis). Differentially expressed genes were identified as described in <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 3</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 3</a> (red, upregulated; blue, downregulated) by comparing gene expression patterns of patients displaying no sign of alteration vs. those from patients with pronounced alteration of a given parameter (see <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 2</a>). Gene lists were annotated with the gene ontology (GO) biological process functional annotation table, and resulting biological term enrichment are shown. (<strong>B</strong>) Evolution of the NAS score and of fibrosis after gastric bypass (GABY). (<strong>B</strong>) Patient stratification according to histological parameters. Patients were histologically graded and classified according to the NAS score, lobular inflammation, or fibrosis stages prior to surgery (M<sub>0</sub>) or 1 year after intervention (M<sub>12</sub>). (<strong>C</strong>) Genes whose expression was either up- or downregulated in lobular inflammation, ballooning, or fibrosis were selected to build 2 gene lists that are either up- or downregulated in the 3 categories (193 and 58 genes respectively, 2-tailed <em>t</em> test, FC &#x0003e; 1.2, <em>P</em> &#x0003c; 0.05). These gene lists were crossed with those containing genes showing an inverse regulation after GABY. Green lines indicate the 103 genes upregulated in either lobular inflammation, ballooning, or fibrosis whose expression is decreased after GABY. Red lines indicate the 36 genes downregulated in either lobular inflammation, ballooning, or fibrosis whose expression is increased after GABY. Gene expression values are expressed relative to normalized control values (no lobular inflammation, ballooning, or fibrosis) arbitrarily set to 1 and expressed as log<sub>2</sub> fold change. (Right) Top ranking hits after a GO term enrichment analysis (Metascape) against biological process (BP), cellular components (CC), or molecular functions (MF) functional annotation tables (FAT) are indicated.</p></div></div></div><p id="__p11">As necroinflammation and ballooning are the hallmark of NASH (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070627">20</a>, <a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070595">37</a>), we generated gene lists containing all up- and downregulated genes in lobular inflammation (grade &#x02265; 2) and ballooning (grade &#x0003e; 1), which correspond to the current concept of definite or moderate-to-severe NASH. This list was combined with that of genes dysregulated in fibrosis (&#x02265;F2) to generate a gene signature corresponding to a &#x0201c;definite NASH + fibrosis&#x0201d; state (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 3</a>). As expected, functional annotation of the upregulated gene list (193 genes) very significantly identified molecular functions related to immune responses and ECM homeostasis, whereas metabolic processes were predominantly identified in the downregulated 58-gene set (data not shown).</p><p id="__p12">Weight loss by BarSur induced liver lesion regression, whereas lifestyle modification resulted in little improvement. We therefore restricted the paired biopsy analysis to patients who, after their initial work-up, went to GABY. BarSur has been previously shown to efficiently normalize biochemical parameters and reverse liver pathological features (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070523">13</a>&#x02013;<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070622">16</a>). The positive effect of GABY on biological constants and on liver histological features was also observed in our cohort (<a href="/pmc/articles/PMC5499370/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>, respectively). Indeed, GABY induced a general regression of the NAFLD activity score (NAS score) and of the fibrosis stage (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>), which correlated with a global downregulation of genes functionally not only associated to the immune and inflammatory response, but also to extracellular space/matrix homeostasis (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 4</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Tables 4, 5, 6</a>). Thus, human NASH and fibrosis induce a transcriptional program strongly related to inflammation and ECM remodeling, processes that can be reversed by GABY.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of bariatric surgery in obese patients</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116554932912" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g008.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g008.jpg" /></a></div><div id="largeobj_idm140116554932912" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="__p13">To identify the genes associated with increased NAFLD/NASH and fibrosis stages (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>) and whose expression can be reverted upon improvement of liver histological parameters by GABY, we assessed the regulation of the 193 upregulated and 58 downregulated genes in the &#x0201c;NASH &#x02013; fibrosis&#x0201d; or &#x0201c;NASH + fibrosis&#x0201d; state before (M<sub>0</sub>) or after GABY (M<sub>12</sub>) (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1C</span></a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 6</a>). The expression of &#x0003e; 50% of these 251 genes was partially or totally normalized after GABY (M<sub>12</sub>: upregulated genes, 103/193; and downregulated genes, 36/58), many of them participating in immune responses and ECM deposition (<em>THBS1</em>/thrombospondin, <em>CLEC7A</em>/<em>dectin1</em>, <em>IL18</em>, chemokine CC and CXC ligands) as shown by GO term enrichment analysis (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1C</span></a>). Thus, our transcriptomic analysis identified a limited set of 139 human genes with functions in inflammation and ECM remodeling whose expression changes in NASH or NASH + fibrosis and is normalized by GABY.</p><p id="__p14" class="p p-last">To make a more stringent selection of genes involved in NASH and fibrosis progression, we assessed which genes dysregulated in our cohort could be validated in other human cohorts. Therefore, two transcriptomic studies were selected (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070561">24</a>, <a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070629">27</a>) to which similar filters (inflammation &#x02265; 2, fibrosis &#x02265; F2) and analysis methods were applied. A comparison of differentially expressed genes in all 3 cohorts, which showed similarly dysregulated biological processes (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 5</a>), generated a human NASH + fibrosis core signature containing 48 upregulated and 10 downregulated genes (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 6</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 7</a>), the former being strongly enriched in genes involved in ECM formation (<em>COL1A1</em> and <em>-2</em>, <em>COL3A1</em>, <em>COL14A1</em>, <em>DPT</em>, <em>FBLN5</em>, <em>LUM</em>, <em>PDGFRA</em>) and inflammatory responses (<em>CCL19</em> and -<em>21</em>, <em>CXCL9</em> and -<em>10</em>, <em>SPP1</em>) (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 6</a>). Very interestingly, the expression of 24 of these 58 genes was normalized after GABY in our cohort, thereby identifying GABY-sensitive human genes with potential pathogenic activity (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 6</a>).</p></div><div id="__sec4" class="sec"><h3>Transcriptional alterations in rodent models of NASH and fibrosis.</h3><p id="__p15" class="p p-first">Conserved cross-species regulatory mechanisms are strongly indicative of shared biological functions. We therefore carried out a transcriptomic meta-analysis of several murine preclinical models that mimic certain aspects of human liver pathology (<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070584">38</a>). Feeding mice a methionine and choline-deficient diet (MCDD) promotes pathological features typical of liver inflammation and early fibrosis without inducing systemic metabolic alterations of human NASH. MCDD has been used in combination with a high-fat diet (HFD) to install NASH in a context of insulin resistance. Although there is no well-established, reproducible model of dietary-induced fibrosis, fibrosis can be chemically induced by carbon tetrachloride (CCl<sub>4</sub>), which induces oxidative damages through conversion of CCl<sub>4</sub> to the trichloromethyl radical <sup>&#x02022;</sup>CCl3 by Cyp2E1, a pericentral hepatocyte-specific enzyme (<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070620">39</a>, <a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070540">40</a>).</p><p id="__p16">We next evaluated whether the human transcriptomic signatures associated with pathological features of NASH are recapitulated in mice fed a HFD/MCDD. Gene expression changes (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 8</a>) were functionally related to inflammatory cell migration, lipid metabolism, responses to TGF&#x003b2; and extracellular matrix organization (upregulated genes), and amino acid and bile acid metabolism (downregulated genes) (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 7</a>). We similarly assessed if HFD feeding combined with CCl<sub>4</sub> reproduced part of the transcriptional alterations observed in human fibrosis. HFD/CCl<sub>4</sub> treatment massively downregulated numerous cytochrome P450 genes, paralleling a strong upregulation of chemokines involved in chemotaxis and enzymes participating in ECM formation (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 8</a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 9</a>), patterns resembling part of the functional programs induced in human fibrosis.</p><p id="__p17">Combining the dysregulated gene sets in the MCD/HF and CCl<sub>4</sub>/HF diet models defined a set of genes characterizing the liver response to experimentally induced NASH or fibrosis, respectively. By comparing the human GABY-sensitive 139-gene list to this murine gene repertoire, we generated a conserved core gene signature of 34 upregulated genes and 8 downregulated genes for NASH + fibrosis (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 10</a>). Quite strikingly, GSEA and GO enrichment analysis of the 34 upregulated genes pointed to functions in epithelial mesenchymal transition and ECM deposition (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2B</span></a>), processes likely to occur simultaneously upon HSC dedifferentiation and fibrogenesis. This conclusion was supported by filtering this list of 34 upregulated genes against ChIP-X databases, showing that their upstream regulatory regions contain bona fide binding sites for PPARs and/or RunX2 and/or Smad transcription factors (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2C</span></a>), all involved in HSC responses to liver injury (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070609">41</a>). Of note, 20 of the 34 upregulated genes display cell-specific expression in normal mouse liver, 8 of them being strongly expressed in HSCs (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>; refs. <a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070539">42</a>, <a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070515">43</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116560864736" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g002.jpg" /></a></div><div id="largeobj_idm140116560864736" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Identifying <em>dermatopontin</em> as a potential contributor to liver fibrosis.</strong><p id="__p60">(<strong>A</strong>) Up- and downregulated genes in mouse models of nonalcoholic steatohepatitis (NASH) or fibrosis and in human cohorts of NASH + fibrosis patients. Gene symbols are indicated in each column. Cell type&#x02013;specific expression is indicated when known (HSC, hepatic stellate cell; KC, Kuppfer cell; HC: hepatocyte; LSEC, liver sinusoidal endothelial cell; CHC, intrahepatic cholangiocyte; NPC, nonparenchymal cell). A complete list of genes can be found in <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 10</a>. Genes whose expression is normalized by gastric bypass (GABY) are highlighted in yellow. (<strong>B</strong>) Top-ranking terms characterizing upregulated genes in advanced NASH. The upregulated gene list was searched against the Hallmark gene sets, gene ontology (GO) biological processes, GO cellular components, and GO molecular functions annotation table, as well as the KEGG pathway database using Metascape. (<strong>C</strong>) Potential regulatory pathways. The upregulated gene list was scanned for the occurrence of actual transcription factor binding site as determined by ChIP-Seq assays from the ENCODE and ChEA databases using the EnrichR web server (<a href="http://amp.pharm.mssm.edu/Enrichr/" ref="reftype=extlink&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://amp.pharm.mssm.edu/Enrichr/</a>) (<a href="#B82" rid="B82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070552">82</a>, <a href="#B83" rid="B83" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070559">83</a>). Positive hits are indicated in red. (<strong>D</strong>) Tissue-specific expression of <em>Dpt</em> in mouse tissues. RNAs were extracted from indicated tissues and analyzed by qPCR. Results are expressed relative to a control value arbitrarily set to 1 (liver) and are the mean &#x000b1; SEM (<em>n</em> = 6). Data were compared using a 2-tailed ANOVA corrected for multiple comparisons using the Dunnett&#x02019;s post hoc test. ***<em>P</em> &#x0003c; 0.005. (<strong>E</strong>) Relative expression of <em>Dpt</em> in mouse purified hepatocytes and hepatic stellate cells. (<strong>F</strong>) Relative expression of <em>DPT</em> in TGF&#x003b2;-stimulated (10 ng/ml, 24 hours) LX2 cells.</p></div></div></div><p id="__p18" class="p p-last">The potential of these genes for human therapeutic intervention and clinical relevance was further assessed by identifying within this 42-gene list those sensitive to GABY, resulting in a 16-gene set (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>) whose properties (dysregulated in human and mouse NASH + fibrosis and normalized by GABY) indicate that they could be potential targets to reverse NASH and fibrosis progression.</p></div><div id="__sec5" class="sec"><h3>DPT expression correlates with human fibrosis.</h3><p id="__p19" class="p p-first">Many of the upregulated genes have already been associated with ECM homeostasis and liver fibrosis, such as <em>Col14a1</em>/<em>undulin</em> (<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070580">44</a>), <em>Col1a1</em>, <em>Col1a2</em>, and <em>Col3a1</em>, as well as <em>Timp1</em> (<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070541">45</a>), <em>Lama2</em> (<a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070607">46</a>), and <em>Lumican</em>/<em>Lum</em> (<a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070534">47</a>). In contrast, the role of <em>Dpt</em> in hepatic pathophysiology is unknown. Previous reports hinted at a possible role of <em>Dpt</em> in dermis ECM homeostasis through an interaction of DPT with fibrin and fibrinogen (<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070558">31</a>, <a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070614">33</a>, <a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070582">47</a>, <a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070529">48</a>). The tissue-specific distribution of <em>Dpt</em> was assessed in several mouse tissues (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2D</span></a>), showing a predominant expression in adipose tissues, skin, and lungs, as previously reported in tissue atlas expression studies (<a href="http://biogps.org/#goto=genereport&#x00026;id=1805" ref="reftype=extlink&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://biogps.org/#goto=genereport&#x00026;id=1805</a>). <em>Dpt</em> expression in the liver was low but detectable, but was strongly enriched (more than 800-fold) in purified HSCS (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2E</span></a>), in line with proteomic and RNA-seq data (<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070597">42</a>, <a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070531">43</a>). In agreement with our predictions (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2C</span></a>), <em>Dpt</em> expression was inducible by TGF&#x003b2; in the human stellate LX2 cell line (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2F</span></a>). These observations, thus, raise the possibility that <em>Dpt</em> could participate in the hepatic fibrotic process, as HSCs are strongly involved in this process (<a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070538">49</a>).</p><p id="__p20">Expressing <em>DPT</em> expression as a function of human liver histological parameters (NAS score, fibrosis stage) indicated a positive correlation of <em>DPT</em> expression with fibrosis but not with the composite NAS score integrating steatosis, lobular inflammation, and ballooning stages (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 9</a> and <a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>). Furthermore, <em>DPT</em> expression decreased after GABY (<a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>), and a paired analysis of fibrosis evolution after GABY revealed a significant decrease in <em>DPT</em> expression upon fibrosis regression by &#x0003e; 1 grade (<a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>). Thus, <em>DPT</em> expression is significantly associated with the fibrosis stage in human liver disease.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116560845808" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g003.jpg" /></a></div><div id="largeobj_idm140116560845808" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>DPT</em> expression correlates with human fibrosis severity.</strong><p id="__p61">(<strong>A</strong>) Human <em>DPT</em> and <em>PPAR</em> expression as a function of the fibrosis stage. <em>PPAR</em><em>&#x003b1;</em>, <em>PPAR</em>&#x003b2;/&#x003b4;, and <em>PPAR</em>&#x003b3; expression levels were extracted from microarray data and expressed relative to control (no fibrosis) arbitrarily set to 1. Expression values are expressed as the mean &#x000b1; SEM (<em>n</em> = 16&#x02013;35) and compared using a 2-tailed ANOVA corrected for multiple comparisons using the Dunnett&#x02019;s post hoc test. *<em>P</em> &#x0003c; 0.05. (<strong>B</strong>) <em>DPT</em> mRNA expression level after gastric bypass (GABY). <em>DPT</em> expression level were assayed by qPCR and expressed relative to a randomly chosen baseline value set to 1. Data are expressed as the mean &#x000b1; SEM and were compared using an unpaired <em>t</em> test (<em>n</em> = 52). (<strong>C</strong>) Correlation between fibrosis evolution and <em>DPT</em> expression in human fibrotic livers. <em>DPT</em> expression was plotted before (M<sub>0</sub>) and after GABY (M<sub>12</sub>) as a function of the fibrosis-stage evolution. Expression values, assayed by qPCR, were compared using a paired <em>t</em> test. (<strong>D</strong>) Scatter plot of differentially expressed genes in carbon tetrachloride&#x02013;treated (CCl<sub>4</sub>-treated) Dpt<sup>+/+</sup> mice. Gene expression was assayed using Affymetrix array (<em>n</em> = 6) and analyzed using the Genespring 14.3 software. Upregulated genes are indicated in red, downregulated genes in green. The fold change (FC) threshold was set at 2 (<em>P</em> &#x0003c; 0.05) and is indicated by the two green lines. The most relevant gene symbols are indicated; a complete listing of induced and repressed genes can be found in <a href="#sd" rid="sd" class=" supplementary-material">supplemental Table 9</a>. <em>Dpt</em> was induced 4-fold. (<strong>E</strong>) Up- and downregulated gene lists underwent a gene ontology (GO) term enrichment against the biological process function annotation table (Metascape, settings: minimum overlap 5, <em>P</em> value cutoff 0.01, minimum enrichment 5). Statistically enriched terms were converted into a network layout in which circle diameters are proportional to the number of genes and the thickness of edges indicates the similarity score. The color scales indicate the <em>P</em> value of the nodes. A complete list of genes can be found in <a href="#sd" rid="sd" class=" supplementary-material">supplemental Table 11</a>.</p></div></div></div><p id="__p21" class="p p-last">We next assessed whether the CCl<sub>4</sub>-induced fibrosis model, which generates pericentral hepatocyte-specific oxidative stress, recapitulates features of human fibrosis. Four-hundred and ninety genes (fold cgange [FC] &#x0003e; 2, <em>P</em> &#x0003c; 0.05, <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 11</a>) were dysregulated in CCl<sub>4</sub>-treated WT mice, which were highly similar to those induced by HFD/CCl<sub>4</sub> treatment (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 8</a>). A robust induction of the expression of <em>Dpt</em> (FC = 4), together with other genes related to ECM organization, was observed, whereas downregulated genes were mostly involved in metabolic processes (<a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3, D and E</span></a>). Interestingly, the fibrosis modulator gene expression pattern in the CCl<sub>4</sub> model resembled the one found in our human cohort, including increased expression of <em>Tgfb</em>, <em>Ctgf</em>, and <em>Pdgfb</em> (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 12</a>). Taking together, these data validate the CCl<sub>4</sub>-induced fibrosis model as a surrogate model for functional studies of genes identified in human fibrosis. We thus investigated whether <em>Dpt</em> modifies fibrosis development using this model.</p></div><div id="__sec6" class="sec"><h3>DPT is a key player in murine liver fibrogenesis.</h3><p id="__p22" class="p p-first">Whole body <em>Dpt</em>-deficient (<em>Dpt</em><sup>&#x02013;/&#x02013;</sup>) mice (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070604">30</a>) did not exhibit major morphometric nor metabolic abnormalities compared with WT littermates, except for an increase in plasma cholesterol (<a href="/pmc/articles/PMC5499370/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Importantly, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) plasma levels, two markers of hepatic injury, and liver collagen content were normal, indicative of the absence of hepatic injury in unchallenged mice (<a href="/pmc/articles/PMC5499370/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). To investigate a functional role of DPT in liver fibrosis progression, <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> or <em>Dpt</em><sup>+/+</sup> mice were next treated with CCl<sub>4</sub> for 4 or 7 weeks.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Biometric and biochemical features of <em>Dpt</em>-null mice</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116554935472" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g009.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g009.jpg" /></a></div><div id="largeobj_idm140116554935472" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/table/T3/?report=objectonly">Open in a separate window</a></div></div><p id="__p23">CCl<sub>4</sub> treatment did not result in differences in liver triglyceride or cholesterol content between WT and <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice after 7 weeks (D49) (<a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4A</span></a>). Plasma ALT and AST levels clearly increased in <em>Dpt</em><sup>+/+</sup> mice in a time-dependent manner (<a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4B</span></a>). In sharp contrast, <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice were partially resistant to CCl<sub>4</sub>-induced hepatic injury, as AST and ALT levels did not increase further after 4 weeks of treatment. Histological analysis evidenced less collagen deposition (<a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4C</span></a>) and hydroxyproline content (<a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4C</span></a>) in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers after a 7-week exposure to CCl<sub>4</sub>. These data therefore identify DPT as a player in oxidative stress&#x02013;induced fibrosis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116560824976" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g004.jpg" /></a></div><div id="largeobj_idm140116560824976" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Dermatopontin is a critical player in the chemically induced fibrotic response.</strong><p id="__p62">(<strong>A</strong>) Hepatic triglyceride and cholesterol content in Dpt<sup>&#x02013;/&#x02013;</sup> mice. Hepatic triglycerides (TG) content was assayed in CCl<sub>4</sub>-treated WT (<em>Dpt</em><sup>+/+</sup>, <em>n</em> = 9) and Dpt-null mice (<em>Dpt</em><sup>&#x02013;/&#x02013;</sup>, <em>n</em> = 8). Data are expressed as the mean &#x000b1; SEM (<em>n</em> = 8&#x02013;9) of mg TG per mg liver protein and were compared using a 2-tailed <em>t</em> test. The <em>P</em> value is indicated. Hepatic cholesterol content was assayed in WT (<em>Dpt</em><sup>+/+</sup>, <em>n</em> = 9) and <em>Dpt</em>-null mice (<em>Dpt</em><sup>&#x02013;/&#x02013;</sup>, <em>n</em> = 8). Data are expressed as mg TG per mg liver protein and were compared using a 2-tailed <em><span class="underline">t</span></em> test. The <em>P</em> value is indicated. (<strong>B</strong>) Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) plasma level in CCl<sub>4</sub>-treated WT or <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice. Mice (<em>n</em> = 9) were treated biweekly for the indicated period (28 or 49 days) with CCl<sub>4</sub>, and liver enzymes were assayed as described (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070569">36</a>). Data are expressed as the mean &#x000b1; SEM of enzymatic units/L (U/l) and were compared using a 2-tailed <em>t</em> test (<em>n</em> = 8&#x02013;9). The <em>P</em> value is indicated. (<strong>C</strong>) Hepatic collagen deposition in CCl<sub>4</sub>-treated <em>Dpt</em><sup>+/+</sup> or <em>Dpt</em>-KO mice treated for 49 days with CCl<sub>4</sub>. Paraffin-embedded liver sections were stained with Sirius red, and the collagen deposition area was quantified with the ImageJ software. Data are expressed as the percentage of the total area and were compared using a 2-tailed Mann Whitney test. <em>P</em> value is indicated. The liver collagen content was measured using a hydroxyproline assay. Results are expressed as the mean &#x000b1; SEM of &#x003bc;g hydroxyproline per g liver and were compared using a 2-tailed <em>t</em> test. The <em>P</em> value is indicated.</p></div></div></div><p id="__p24" class="p p-last">We then assessed the impact of <em>Dpt</em> gene deficiency on the CCl<sub>4</sub>-induced transcriptional response (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 13</a>). The hepatic transcriptional response after 7 weeks of exposure to CCl<sub>4</sub> was compared between <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> and <em>Dpt</em><sup>+/+</sup> mice by GSEA (<a href="/pmc/articles/PMC5499370/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5A</span></a>). CCl<sub>4</sub> induced, in both genetic backgrounds, an inflammatory response and decreased expression of cytochrome P450 expression. However, several distinctive responses were noted. CCl<sub>4</sub> induced in <em>Dpt</em><sup>+/+</sup> mice, but not in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice, the expression of components of the integrin and Hippo signaling pathways. Accordingly, induction of the expression of the profibrotic <em>Ctgf</em> (<a href="#B50" rid="B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070628">50</a>) was significantly lower in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice (<a href="/pmc/articles/PMC5499370/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5B</span></a>), as well as the expression of <em>desmin</em> (<em>Des</em>), a marker of HSC activation (<a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070553">51</a>), and of <em>Cidec</em>, which may contribute to liver damage (<a href="#B52" rid="B52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070520">52</a>). CCl<sub>4</sub>-treated <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> mice displayed an enrichment in genes of the protective <em>Clec7a/Dectin-1</em> pathway (<a href="#B53" rid="B53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070588">53</a>), indicative of macrophage skewing toward an antiinflammatory phenotype. The nuclear receptor PPAR&#x003b3;, which also exhibits antifibrotic activity, was also upregulated in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers (<a href="#B54" rid="B54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070610">54</a>) (<a href="/pmc/articles/PMC5499370/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5B</span></a>). Thus, loss of <em>Dpt</em> expression triggers coordinated transcriptional responses in the liver, potentially decreasing proliferative responses and ECM deposition, while favoring antiinflammatory responses. Since <em>Ctgf</em> expression is regulated by TGF&#x003b2;/SMAD3 signaling (<a href="#B55" rid="B55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070617">55</a>), we further investigated whether activation of the TGF&#x003b2; pathway is altered in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers. SMAD3 and phospho-SMAD3 protein levels were significantly increased by CCl<sub>4</sub> treatment in Dpt<sup>+/+</sup> livers, but not in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers (<a href="/pmc/articles/PMC5499370/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5C</span></a> and <a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 10</a>). Since no alterations in <em>Smad3</em> RNA expression were observed, TGF&#x003b2; responsiveness thus appears regulated by <em>Dpt</em> deficiency through posttranslational mechanisms. Such mechanisms may also implicate miRNAs, among which miR21 upregulation has been shown to enhance TGF&#x003b2;-mediated pro-fibrogenic responses (<a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070611">56</a>). Interestingly, CCl<sub>4</sub> treatment increased miR21 levels to a lesser extent in livers of <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> compared with <em>Dpt</em><sup>+/+</sup> mice (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 11</a>). In contrast, levels of miR122, an abundantly expressed and functionally important hepatic miRNA (<a href="#B57" rid="B57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070543">57</a>), were unaltered. Taken together, our results are thus in line with a role for DPT to sustain activation of the TGF&#x003b2; pathway as observed in skin (<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070537">34</a>, <a href="#B58" rid="B58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070576">58</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC5499370/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116560812752" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g005.jpg" /></a></div><div id="largeobj_idm140116560812752" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Dpt<sup>&#x02013;/&#x02013;</sup> mice display an altered response to CCl<sub>4</sub>-induced injury.</strong><p id="__p63">(<strong>A</strong>) The expression of hepatic genes was monitored using Affymetrix microarrays after RNA extraction from CCl<sub>4</sub>-treated <em>Dpt</em><sup>+/+</sup> or Dpt<sup>&#x02013;/&#x02013;</sup> mouse livers (<em>n</em> = 6). Gene expression patterns were compared using an unpaired <em>t</em> test (FC &#x0003e; 2, <em>P</em> &#x0003c; 0.05) and are shown as a scatter plot. Differentially expressed gene lists were analyzed by gene set enrichment analysis (GSEA); top-ranking gene sets are indicated. The two most extreme green lines indicate a fold change of 1.2. (<strong>B</strong>) Gene expression values for fibrosis-related genes. Normalized gene expression values were extracted from microarray data and were expressed relative to expression levels detected in unchallenged <em>Dpt</em><sup>+/+</sup> mouse livers. (<strong>C</strong>) SMAD3 and phospho-SMAD3 protein levels. Quantification of protein levels after WES-based analysis (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 10</a>) are shown. Results are expressed as the mean &#x000b1; SEM of densitometric arbitrary units (<em>n</em> = 6&#x02013;8). Data were compared using a 2-tailed ANOVA corrected for multiple comparisons using the Dunnett&#x02019;s post hoc test. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x0003c; 0.01, ***<em>P</em> &#x0003c; 0.005.</p></div></div></div></div><div id="__sec7" class="sec sec-last"><h3>Dpt expression is downregulated upon PPAR&#x003b1; activation in vivo.</h3><p id="__p25" class="p p-first">Human biopsy analysis showed that progressive fibrosis is associated with decreased PPAR&#x003b1; expression and increased <em>DPT</em> expression (<a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>), whereas GABY decreases fibrosis and <em>Dpt</em> expression (<a href="/pmc/articles/PMC5499370/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3, B and C</span></a>) while increasing <em>PPAR&#x003b1;</em> expression (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070619">35</a>). Therefore, we analyzed whether PPAR&#x003b1; activation, which promotes NASH and fibrosis regression in rodents, could modulate <em>Dpt</em> expression.</p><p id="__p26">This was first investigated in the CCl<sub>4</sub> model, in which liver injury is accompanied by increased expression of <em>Dpt</em> and <em>Col1a1</em>, an early marker of the fibrotic response (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6, A and B</span></a>). Interestingly, the induction of these genes was blunted by both elafibranor (GFT505), a mixed PPAR&#x003b1;/&#x003b4; agonist active in murine models of NASH (<a href="#B59" rid="B59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070592">59</a>) and in NASH patients (<a href="#B60" rid="B60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070602">60</a>) (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6A</span></a>), and fenofibrate (FF), a PPAR&#x003b1;-specific agonist (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6B</span></a>). Interestingly, <em>Col1a1</em> and <em>Dpt</em> expression was already markedly increased in a diet-induced model of NASH with undetectable histological fibrosis (HF, high-sucrose, cholesterol [HF/HS/Ch]) (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6C</span></a>). Treatment of these mice with GFT505 also blunted the diet-induced <em>Col1a1</em> and <em>Dpt</em> expression. Finally, AAV8-mediated restoration of PPAR&#x003b1; expression in MCDD-fed, PPAR&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice, which display enhanced but reversible NASH and fibrosis (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070571">36</a>, <a href="#B61" rid="B61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070579">61</a>), restored PPAR&#x003b1; expression in the liver (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 12</a>), prevented fibrosis progression; ref. <a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070591">36</a>), and decreased <em>Col1a1</em> and <em>Dpt</em> expression (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6D</span></a>). The regression of MCDD-induced fibrosis involved a transrepressive mechanism, as both WT and the DNA binding&#x02013;deficient PPAR&#x003b1; mutant (PPAR&#x003b1;diss) (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070605">36</a>) repressed MCD-induced <em>Dpt</em> and <em>Col1a1</em> expression (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6D</span></a>). Taken together, these data indicate that PPAR&#x003b1; interferes with <em>Dpt</em> induction both in NASH and fibrosis models.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140116554938496" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5499370_jciinsight-2-92264-g006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is jciinsight-2-92264-g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-g006.jpg" /></a></div><div id="largeobj_idm140116554938496" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5499370/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC5499370/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>PPAR&#x003b1; activation regulates <em>Dpt</em> expression.</strong><p id="__p64">(<strong>A</strong>) Mouse <em>Dpt</em> gene regulation by PPAR&#x003b1;/&#x003b4; agonism. Mice were submitted to CCl<sub>4</sub> exposure and treated or not with elafibranor/GFT505. Gene expression was monitored by qPCR. Results are expressed relative to a control value arbitrarily set to 1 and are the mean &#x000b1; SEM (<em>n</em> = 4&#x02013;8). Data were compared as above. **<em>P</em> &#x0003c; 0.01, ***<em>P</em> &#x0003c; 0.005. (<strong>B</strong>) Mouse <em>Dpt</em> gene regulation by PPAR&#x003b1; agonism. Mice were fed either a normal chow (CD) or a high-fat diet (HFD) and submitted to CCl<sub>4</sub> exposure and treated or not with fenofibrate (200 mpk/day). Gene expression was monitored by qPCR. Results are expressed relative to a control value arbitrarily set to 1 and are the mean &#x000b1; SEM (<em>n</em> = 5&#x02013;8). Data were compared as above. **<em>P</em> &#x0003c; 0.01, ***<em>P</em> &#x0003c; 0.005. Data were compared using a 2-tailed ANOVA corrected for multiple comparisons using the Dunnett&#x02019;s post hoc test. (<strong>C</strong>) <em>Dpt</em> regulation in a diet-induced model of NASH. Mice were fed a high-sucrose, HFD supplemented with 0.5% cholesterol and treated or not by elafibranor. Results were obtained and processed as in <strong>A</strong> (<em>n</em> = 8). (<strong>D</strong>) Mouse <em>Dpt</em> gene regulation by hepatic PPAR&#x003b1;. Fourteen-week-old PPAR&#x003b1;-KO mice (<em>n</em> = 11) were transduced with AAV8-TBG-PPAR&#x003b1; viral particles (PPAR&#x003b1;) or AAV8-TBG-PPAR&#x003b1;diss or not and were fed 2 weeks later a chow diet (CD) or a methionine and choline deficient diet (MCDD) for 3 weeks. Diets were then supplemented with 0.2% Wy14,643, a synthetic PPAR&#x003b1; agonist, for 5 days. RNAs were extracted and analyzed by RT-PCR as described (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070566">36</a>). Results are expressed relative to a control value arbitrarily set to 1 (CD) and are the mean &#x000b1; SEM (<em>n</em> = 7). Data were compared using a 2-tailed ANOVA corrected for multiple comparisons using the Dunnett&#x02019;s post hoc test. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x0003c; 0.01. (<strong>E</strong>) Relative expression of <em>Dpt</em> and <em>PPAR</em><em>&#x003b1;</em> in liver cells and cell lines. Transcript abundance was assayed by qPCR (<em>n</em> = 3) and expressed relative to highest expressing cells arbitrarily set to 100 (black bars). mPH, mouse primary hepatocytes; mHSC, mouse primary hepatic stellate cells. (<strong>F</strong>) Relative expression of genes in TGF&#x003b2;1-treated cells. mRNAs were quantified by qPCR and expressed relative to control conditions arbitrarily set to 1 (<em>n</em> = 2&#x02013;3). Values are expressed as mean &#x000b1; SEM and compared using the Dunnett&#x02019;s post hoc test. *<em>P</em> &#x0003c; 0.05, **<em>P</em> &#x0003c; 0.01, ***<em>P</em> &#x0003c; 0.005. (<strong>G</strong>) Screenshot of the IGV browser at the <em>Dpt</em> locus. Wy, Wy14,643. (<strong>H</strong>) Screenshot of the IGV browser at the <em>Acox1</em> and <em>Tgfb1</em> locus. (<strong>I</strong>) Screenshot of the IGV browser at the <em>Klf6</em> locus. (<strong>J</strong>) Relative expression of <em>TGF</em><em>&#x003b2;</em><em>1</em> and of <em>Klf6</em>. Gene expression were measured and expressed as in <strong>D</strong>.</p></div></div></div><p id="__p27">To determine the mechanism of PPAR&#x003b1; regulation of <em>Dpt</em> expression, we performed a survey of our own or publicly available data and found that in vivo treatment of mice with neither live bacteria, tunicamycin, IL-1, nor IL-6 (ref. <a href="#B62" rid="B62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070509">62</a> and data not shown) failed to induce <em>Dpt</em> expression, thereby excluding the TLR4, ER stress, NF&#x003ba;B, and STAT3 signaling pathways as major contributors to <em>Dpt</em> regulation. In contrast, <em>Dpt</em> expression is increased in <em>Pdgf-c</em> transgenic mice, which display chronic liver inflammation, liver injury, and fibrosis (<a href="#B63" rid="B63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070613">63</a>) in a <em>Tgf</em>&#x003b2;/<em>Smad3-</em>dependent manner (<a href="#B64" rid="B64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070544">64</a>). These observations, in line with predictions based on ChIP-Seq data (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2C</span></a>) and our in vitro functional data (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2F</span></a>), point to a major role of the TGF&#x003b2; signaling pathway in the regulation of <em>Dpt</em> expression.</p><p id="__p28">Since PPAR&#x003b1; has previously been reported to blunt TGF&#x003b2; signaling in vascular smooth muscle cells (<a href="#B65" rid="B65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070621">65</a>), we investigated whether such a cell-autonomous process could also occur in hepatic LX2 stellate cells, which express <em>PPAR&#x003b1;</em> and <em>Dpt</em> similarly as primary mouse HSCs (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6E</span></a>). PPAR&#x003b1; activation with the selective agonist GW647 induced the expression of the canonical PPAR&#x003b1; target gene <em>Cpt1</em> but did not influence TGF&#x003b2;-induced <em>Dpt</em> expression in LX2 (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6F</span></a>) as well as in mouse stellate EMS404 (data not shown) cells. Furthermore, ChIP-Seq analysis of MCDD-treated, WT mouse livers treated or not with the PPAR&#x003b1; agonist Wy14,643 did not identify any genomic binding of PPAR&#x003b1; in the vicinity of the <em>DPT</em> gene, in contrast to the PPAR&#x003b1; target gene <em>Acox1</em> (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6, G and H</span></a>). Thus, a direct genomic interference of PPAR&#x003b1; with TGF&#x003b2;-regulated transcription, as well as interference of PPAR&#x003b1; with the TGF&#x003b2; signaling pathway itself, is an unlikely mechanism for <em>Dpt</em> repression by PPAR&#x003b1;.</p><p id="__p29" class="p p-last">Other PPAR&#x003b1; genomic binding events were further monitored in MCDD-fed mouse liver to identify processes upstream of TGF&#x003b2; signaling that are potentially targeted by PPAR&#x003b1; (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6, H and I</span></a>). The region encompassing the <em>Tgfb1</em> gene, as well as that of the <em>Klf6</em> locus, displayed modest but detectable increase in density of PPAR&#x003b1; within their coding regions, indicating a possible control by PPAR&#x003b1; of their expression. This hypothesis was confirmed in PPAR&#x003b1;-restored mouse liver, in which MCDD feeding increased the expression of both <em>Tgf&#x003b2;1</em> and <em>Klf6</em>, a known transactivator of the <em>Tgf&#x003b2;1</em> gene (<a href="#B66" rid="B66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070587">66</a>, <a href="#B67" rid="B67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070570">67</a>) and which are repressed upon PPAR&#x003b1; or PPAR&#x003b1;diss activation (<a href="/pmc/articles/PMC5499370/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6J</span></a>). Taken together, these data suggest that PPAR&#x003b1; controls <em>Tgf&#x003b2;1</em> expression, most likely in hepatocytes, through direct or indirect mechanisms that remain to be fully explored.</p></div></div><div id="__sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec8title">Discussion</h2><p id="__p30" class="p p-first">Monitoring gene expression changes at graded stages of the disease is a sensitive method to identify cellular processes leading to pathological states. Moreover, NASH and fibrosis reversibility suggests that at least part of the transcriptomic alterations are also reversible, allowing to identify gene products that are potentially causative of the pathological process. Unsupervised hierarchical clustering of our gene expression data did not allow a clear-cut identification of patient categories. This has already been observed in other studies (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070536">22</a>, <a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070557">24</a>, <a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070623">26</a>), a pitfall probably relating to interindividual heterogeneity of the disease and the adaptive nature of the pathological response likely to trigger subtle changes in gene expression. Cohort stratification on the basis of metabolic parameters also did not identify massively dysregulated pathways. In contrast, a histologically based stratification, hence reflecting NAFLD severity, identified clusters of genes with specific functions in inflammation and ECM homeostasis. As a gene-by-gene comparison of transcriptomic studies of human NAFLD biopsies (our study and refs. <a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070532">22</a>, <a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070522">24</a>, <a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070521">26</a>, <a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070608">27</a>) revealed only a few overlapping genes, likely to result from different threshold and statistical tests applied to each study, we undertook a meta-analysis of available microarray datasets on histologically graded samples, although we were aware that such an approach also suffers from methodological biases such as nonstandardized tissue sampling, handling, and histological characterization and cross-platform variability. Our meta-analysis isolated 48 upregulated genes that we propose as a human NASH and fibrosis core gene signature (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 6</a>). Remarkably, GO term enrichment pointed mainly to wound-healing processes and ECM organization as the predominantly dysregulated biological processes in progression toward fibrosis, in agreement with most of the literature.</p><p id="__p31">This refined analysis was made possible due to specific features of our cohort. As obesity is a risk factor for NAFLD, our cohort was derived from an obesity clinic program in which patients are prospectively screened for NAFLD. Although selecting for obese patients may introduce a bias in our study, the resulting cohort encompasses the whole spectrum of NAFLD, including patients that ultimately appear free of NAFLD and could serve as an internal control group, in contrast to tertiary hepatology clinic patient cohorts. Known diabetics were not included, as preexisting diabetes and its treatment(s), often long-standing, could have had an important impact on disease severity at baseline and hence represent major confounders. Patients who were diagnosed with diabetes upon inclusion in the program &#x02014; and hence de novo diabetics &#x02014; were, however, included. Although the screening-based selection of patients and the inclusion of de novo diabetics argue for the general applicability of our results, a confirmation in other types of cohorts is obviously warranted.</p><p id="__p32">The assessment of causal involvement of gene products and/or pathways in pathology cannot be made from cross-sectional analysis and is difficult to evaluate in patients outside the setting of specific pharmacological intervention studies. The paired biopsy analysis presented here was restricted to patients who underwent GABY, as it caused the most pronounced improvement (<a href="/pmc/articles/PMC5499370/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>; ref. <a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070574">16</a>), in contrast to a weight -management program during which only a few patients achieved substantial improvement and resolution of NASH. This paired analysis, restricted to the liver and purely based on liver histology, identified genes whose dysregulated expression at specific stages of NAFLD was restored after GABY. As GABY induces specific alterations that contribute to its effect beyond what is attributable to weight loss, we propose that the observed changes in gene expression are mainly related to the histological improvement and not to the surgical procedure per se. We also estimate that our approach is the closest one can get in addressing the causal relationship between gene dysregulation and disease progression in NASH patients outside of the setting of a drug intervention trial.</p><p id="__p33">An interspecies comparison further restricted the identified gene list to 34 up- and 8 downregulated genes, 16 being sensitive to GABY. GO analysis and identification of putative regulatory pathways narrowed our search to PPAR-, TGF&#x003b2;-, or YAP/Hippo-dependent processes in HSCs. DPT was identified as an potential novel component of the liver fibrotic response that is specifically expressed in HSC (<a href="/pmc/articles/PMC5499370/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>; refs. <a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070562">42</a>, <a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070615">43</a>). Our combined analysis, as well as a more limited study (<a href="#B68" rid="B68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070551">68</a>), demonstrated <em>DPT</em> upregulation in the liver of NASH patients. This finding was not confirmed in a recent cross-species transcriptomic study, which relied on a cohort stratification based on the composite NAS score; this score does not isolate the fibrosis component of the disease (<a href="#B69" rid="B69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070589">69</a>) and therefore precludes the detection of altered <em>Dpt</em> expression (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Figure 9</a>). In order to gain further insight in the potential novel role of DPT suggested by the human gene expression data analysis, further studies were conducted in preclinical models.</p><p id="__p34">Phenotyping of <em>Dpt</em>-null mice did not evidence gross metabolic alterations. Previous studies suggested a role for DPT in skin wound healing and ECM maturation (<a href="#B70" rid="B70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070581">70</a>, <a href="#B71" rid="B71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070575">71</a>). Strikingly, DPT deficiency protected the liver from increased collagen deposition in the CCl<sub>4</sub>-induced fibrosis model (<a href="/pmc/articles/PMC5499370/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>), similar as in cutaneous fibrosis (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070601">30</a>, <a href="#B58" rid="B58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070517">58</a>). The hepatic transcriptional response to CCl<sub>4</sub> was impacted by Dpt deficiency. Whereas many HSC activation markers were still significantly increased in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers, GSEA and gene-by-gene analysis revealed that the pro-fibrotic Hippo pathway and its target gene <em>Ctgf</em> were less activated in Dpt<sup>&#x02013;/&#x02013;</sup> livers. In addition, increased expression of the alternatively activated macrophage marker Clec7a, of the elastase Mmp12, and of PPAR&#x003b3; &#x02014; all of them reportedly protective against fibrosis &#x02014; was detected in Dpt<sup>&#x02013;/&#x02013;</sup> mouse liver. DPT therefore likely plays a role in signal transduction, as its cell-specific expression in HSC, a major contributor to fibrogenesis, results in increased ECM deposition, hence altering cell-to-cell communication. DPT interacts with decorin, which influences collagen fibrillogenesis, and increases TGF&#x003b2; signaling (<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070567">34</a>). Globally increased SMAD3 activation was observed in <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers, accompanied by increased SMAD3 protein steady state levels. Taken together, these data suggest that <em>Dpt</em> deficiency interferes with signal transduction pathways involved in pro-fibrotic responses. While these conclusions are based on the use of a whole body <em>Dpt</em>-KO model, and therefore may imply indirect contributions of other Dpt-expressing organs, it is worth noting that CCl<sub>4</sub>-induced damages are liver specific, as they stem from the conversion of CCl<sub>4</sub> to the <sup>&#x02022;</sup>CCl3 radical by CypP450 2E1, which is exclusively expressed in the centrilobular region of the liver (<a href="#B72" rid="B72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070618">72</a>).</p><p id="__p35">The regulation of <em>Dpt</em> gene expression is poorly characterized. <em>Dpt</em> promoter hypermethylation correlates with decreased <em>DPT</em> expression in human hepatocarcinoma (<a href="#B73" rid="B73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070508">73</a>), and vitamin D or glucocorticoid receptor activation increases <em>DPT</em> expression in human BM mesenchymal stem cells (<a href="#B74" rid="B74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070626">74</a>, <a href="#B75" rid="B75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070550">75</a>). PPAR&#x003b1;/NR1C1 is a nuclear receptor whose activation results in the normalization of atherogenic dyslipidemia. This effect is due to the transcriptional control of PPAR&#x003b1; target genes involved in fatty acid and lipoprotein metabolism (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070527">18</a>). The mechanisms of antiinflammatory and antifibrotic actions of PPAR&#x003b1; are distinct from its metabolic functions and are usually considered to result from a cell autonomous, transrepressive mechanism (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070542">36</a>). Increased <em>Dpt</em> expression in fibrotic conditions was repressed by WT PPAR&#x003b1; and the DNA binding&#x02013;crippled PPAR&#x003b1;diss mutant, indicating that PPAR&#x003b1; represses <em>Dpt</em> expression through a transrepressive mechanism. Transcriptomic and PPAR&#x003b1; cistrome analysis converged to demonstrate that PPAR&#x003b1; acts, at least in part, by decreasing the expression of <em>Klf6</em>, a <em>Tgf&#x003b2;1</em> gene transactivator, and of <em>Tgf&#x003b2;1</em> itself, but not by interfering with the TGF&#x003b2; signaling pathway. This contrasts with the cell-autonomous transrepression of NF&#x003ba;B-activated genes by PPAR&#x003b1; in multiple systems (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070547">18</a>), suggesting that beneficial antiinflammatory and antifibrotic activities of PPAR&#x003b1; agonists stem from cell-specific effects in the fibrotic liver and whose mechanisms and sites of action remain to be identified.</p><p id="__p36" class="p p-last">Transcriptomic exploration of several subtypes of NAFLD from normal liver to cirrhosis, instead of the usual dichotomous approach, combined with a meta-analysis of our and other datasets allowed the definition of a molecular signature of NASH + fibrosis. This molecular signature evolved concomitantly with the regression of histological injuries after GABY, suggesting that they are potential players in NAFLD pathophysiology and hence targets for pharmacological therapy. Further identification of DPT&#x02019;s role in mouse fibrosis and of its regulation by PPAR&#x003b1; ligands active in human pathology validates our approach and provides further grounds to investigate mechanisms at play in human NAFLD.</p></div><div id="__sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec9title">Methods</h2><div id="__sec10" class="sec sec-first"><h3>Patients</h3><p id="__p37" class="p p-first-last">The metabolic work-up is described in detail in the Supplemental Materials section.</p></div><div id="__sec11" class="sec"><h3>Human liver biopsies</h3><p id="__p38" class="p p-first-last">Biopsies were collected from overweight individuals visiting the Obesity Clinic at the Antwerp University Hospital as reported previously (<a href="#B76" rid="B76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070524">76</a>). Patients who presented at the clinic for a problem of overweight/obesity were prospectively screened for the presence of NAFLD and, if suspected (based on preset criteria relying on abnormal blood biochemistry assays [ALT, AST, &#x003b3; glutamyl-transferase (&#x003b3;GT)] or ultrasound features), were offered a liver biopsy. Exclusion criteria were alcohol consumption, previous BarSur, liver diseases other than NAFLD, and lipid-lowering treatments. Patients with diagnosed diabetes were not included, as diabetes and its associated treatments were considered as major confounding factors that might have influenced the course of the disease before entering the program. Patients who were de novo diagnosed with diabetes at the baseline work-up were, however, included. Patients afterward entered a weight-management program, and some subsequently underwent GABY. A liver biopsy was repeated after 1 year of follow-up, if the patient consented (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070513">35</a>).</p></div><div id="__sec12" class="sec"><h3>Histological scoring of human liver biopsies</h3><p id="__p39" class="p p-first-last">All biopsies were stained (H&#x00026;E stain, Sirius red stain, reticulin stain, Perl&#x02019;s iron stain) and blind-scored by two experienced pathologists. The different histological features of NAFLD were assessed using the NASH Clinical Research Network (NASH CRN) Scoring System as described previously (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070590">35</a>).</p></div><div id="__sec13" class="sec"><h3>RNA extraction and quantitative PCR</h3><p id="__p40" class="p p-first-last">RNA extraction, purification, and processing were described previously (<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070530">35</a>). Quantification and purity of RNA were assessed using a Nanodrop device (Nanodrop Technologies, Thermo Scientific). RNA was reverse-transcribed using the High-Capacity cDNA archive kit (Applied Biosystems) following the manufacturer&#x02019;s recommendations. mRNAs were analyzed using the SYBR green Brilliant II fast kit (Agilent Technologies) on an Mx3005p apparatus (Agilent Technologies). mRNA levels were normalized to the 36B4 gene level, and the fold induction was calculated using the cycle threshold (&#x00394;&#x00394;CT) method (<a href="#B77" rid="B77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070549">77</a>).</p></div><div id="__sec14" class="sec"><h3>Microarray analysis</h3><p id="__p41" class="p p-first">Transcriptome analysis with Affymetrix GeneChip arrays (HuGene 2.0 ST or MoGene 2.0 ST) was performed as described (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070599">36</a>). All liquid handling steps were performed by a GeneChip Fluidics Station 450, and GeneChips were scanned with a GeneChip Scanner 3000-7G (Affymetrix) using Command Console v4.1.2. Quality controls were performed using the Affymetrix expression console. Proprietary .CEL files were imported into Genespring (v13.1.1, Agilent Technologies) and analyzed to identify dysregulated gene patterns as described below.</p><p id="__p42">Total RNA was extracted from liver biopsies. Single-stranded cDNA was prepared from 100 to 300 ng of total RNA with the GeneChip WT PLUS Reagent Kit (Affymetrix). After end-labeling and hybridization, signals were collected and normalized by the robust multiarray average (RMA) method, and the baseline was adjusted to the median of all samples (<em>n</em> = 87). The 5% lowest-expressed genes were filtered out, thereby identifying 37,500 entities (out of 44,629) displaying a detectable expression. A gene-level dataset was created on which quantile normalization was applied. A gene set was created that excluded all nonprotein-encoding genes and those displaying no or low variation (FC &#x0003c; 1.2) in expression values. This generated a 6,925-gene list coding for mRNAs with known functions (<a href="#sd" rid="sd" class=" supplementary-material">Supplemental Table 1</a>) against which all further analysis was performed. SOM clustering was performed with a squared Euclidean distance metric and 1,500 iterations allowing for 10 gene clusters to be identified. Figures were exported from Genespring as .TIF files and processed using Corel Photopaint X3 and CorelDraw X3.</p><p id="__p43" class="p p-last">Functional annotation of identified gene clusters was carried out using the DAVID (<a href="#B78" rid="B78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070577">78</a>) and the Metascape (<a href="#B79" rid="B79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070564">79</a>) web portals. Term enrichment was obtained from the Online Mendelian Inheritance in Man (OMIM), Protein Information Resource (PIR), GO, Biocarta and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Other human datasets were imported from the GEO repository (GSE <a id="__tag_624070630" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE48452" ref="/geo/query/acc.cgi?acc=GSE48452"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE48452","term_id":"48452"}}</span>GSE48452</a>, <a id="__tag_624070631" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE49541" ref="/geo/query/acc.cgi?acc=GSE49541"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE49541","term_id":"49541"}}</span>GSE49541</a>; refs. <a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070526">24</a>, <a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070514">27</a>) and processed as in house-generated data. Mouse transcriptomics data were imported from the GEO <a id="__tag_624070633" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE73985" ref="/geo/query/acc.cgi?acc=GSE73985"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE73985","term_id":"73985"}}</span>GSE73985</a> dataset (HFD/CCl4-treated mice) and from the GEO <a id="__tag_624070632" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE35961" ref="/geo/query/acc.cgi?acc=GSE35961"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE35961","term_id":"35961"}}</span>GSE35961</a> dataset (HFD/MCDD-fed mice; ref. <a href="#B80" rid="B80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070612">80</a>).</p></div><div id="__sec15" class="sec"><h3>Animal experimentation and biochemical and histological analyses</h3><div id="__sec16" class="sec sec-first"><p></p><h4 class="inline">CCl<sub>4</sub>-induced fibrosis in Dpt-KO mice. </h4><p id="__p44" class="p p-first">A pilot scale experiment was carried out in which 10- to 12-week-old female <em>Dpt</em>-null mice (Riken BRC; ref. <a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070578">30</a>) (<em>n</em> = 3) and their WT littermates (<em>n</em> = 4) were s.c. injected for 6 weeks by CCl<sub>4</sub> (Sigma-Aldrich, 0.1 ml/kg of a 1% solution in sterile olive oil, twice a week). Livers were harvested 24 hours after the last injection. Fibrosis was histologically quantified (Sirius red staining), and <em>Dpt</em><sup>&#x02013;/&#x02013;</sup> livers showed an approximately 70% lower collagen deposition after CCl<sub>4</sub> treatment when compared with <em>Dpt</em><sup>+/+</sup> livers. A power calculation using this size of the effect and an estimated SD of 40% for a <em>P</em> value &#x0003c; 0.05 yielded a sample size of 7 (G*Power, University of Dusseldorf, Dusseldorf, Germany; ref. <a href="#B81" rid="B81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070519">81</a>).</p><p id="__p45" class="p p-last">The full-scale CCl<sub>4</sub> experiment was thus performed in 10- to 12-week-old female <em>Dpt</em>-null mice (<em>n</em> = 13) and their WT littermates (<em>n</em> = 9). Mice (~25 g) were treated 3 times a week with 0.1 ml/kg of a 2% CCl<sub>4</sub> solution for 1 week, then 4% (week 2), 5% (week 3), 6% (week 4), and 8% (week 5-8). Livers were harvested 24 hours after the last injection.</p></div><div id="__sec17" class="sec"><p></p><h4 class="inline">CCl<sub>4</sub>-induced fibrosis in C57Bl/6J mice. </h4><p id="__p46" class="p p-first-last">C57Bl/6J mice (Charles River Laboratories) were fed a CD diet and exposed or not to CCl<sub>4</sub> for 3 weeks (with 0.2 ml/kg/day) 3 times a week (<em>n</em> = 8&#x02013;12). GFT505 or fenofibrate were incorporated in the diet to achieve a 10 mpk/day or a 200 mpk/day dosage, respectively. Livers were harvested 48 hours after the last injection.</p></div><div id="__sec18" class="sec"><p></p><h4 class="inline">HF/HS/Ch. </h4><p id="__p47" class="p p-first-last">C57Bl/6J mice were fed either a CD or a HF/HS/Ch diet with 36% fat, 43.2% sucrose, and 0.5% cholesterol for 27 weeks (<em>n</em> = 9&#x02013;12). GFT505 was incorporated in the diet to achieve a 10 mpk/day dosage.</p></div><div id="__sec19" class="sec"><p></p><h4 class="inline">MCDD. </h4><p id="__p48" class="p p-first-last">The MCDD or a CD was administered for 28 days to AAV-TBG-EGFP&#x02013; or AAV-TBG-PPAR&#x003b1;&#x02013;injected PPAR&#x003b1;-deficient mice. The synthetic PPAR&#x003b1; agonist Wy14,643 was incorporated in the diet (0.2%) (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070533">36</a>).</p></div><div id="__sec20" class="sec sec-last"><p></p><h4 class="inline">Transcript profiling. </h4><p id="__p49" class="p p-first-last">The microarray dataset is available at GEO <a id="__tag_624070634" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE83452" ref="/geo/query/acc.cgi?acc=GSE83452"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE83452","term_id":"83452"}}</span>GSE83452</a>.</p></div></div><div id="__sec21" class="sec"><h3>Biochemical and histological assays</h3><p id="__p50" class="p p-first-last">Mice were weighed, and food was removed. Blood samples were taken after a 4-hour fasting by retro-orbital sinus punction under isoflurane anesthesia for free fatty acid, cholesterol, triglyceride, ALT, and AST assays (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_624070624">36</a>). Mice were euthanized by cervical dislocation, and livers were weighed. The median lobes were fixed in 4% formaldehyde and embedded in paraffin for histological analysis, and remaining lobes were snap-frozen in liquid nitrogen for further analysis. Fibrosis assessment was carried out by staining liver sections with a 0.1% solution of Sirius red in 1.3% saturated aqueous picric acid solution (Sigma-Aldrich). Ten to 15 microscopic fields of each liver section were randomly chosen and microscopically photographed at a 150-fold magnification. The area occupied by collagen was quantitated by morphometry using ImageJ and expressed as a percentage of total cross-sectional area. The hydroxyproline assay was performed on 50 mg of liver, which was hydrolyzed in 6 M HCl and processed for the colorimetric assay according to the manufacturer&#x02019;s instructions (Quickzyme Biosciences).</p></div><div id="__sec22" class="sec"><h3>Electrophoresis and Western blotting</h3><p id="__p51" class="p p-first-last">Proteins (100 &#x003bc;g) from liver extracts were separated by 10% SDS-PAGE and blotted onto a PVDF membrane (Hybond-P, GE Healthcare). Anti-PPAR&#x003b1; (sc-9000, Santa Cruz Biotechnology), anti&#x02013;&#x003b2;-actin (sc-1616, Santa Cruz Biotechnology), anti&#x02013;phospho-SMAD3 (ab52903, Abcam), and anti-SMAD3 (ab40854, Abcam) were used.</p></div><div id="__sec23" class="sec"><h3>Statistics</h3><p id="__p52" class="p p-first-last">All data were analyzed using the GraphPad Prism 6 software (GraphPad Software Inc.) or the Genespring 14.3 software (Agilent Technologies). Statistical analysis parameters are indicated in the legend to figures; <em>P</em> &#x0003c; 0.05 was generally considered as significant</p></div><div id="__sec24" class="sec sec-last"><h3>Study approval</h3><p id="__p53" class="p p-first-last">The human study protocol is part of the Hepadip protocol (Belgian registration number B30020071389) and approved by the Ethical Committee of the Antwerp University Hospital (file 6/25/125). Mouse experimental protocols were approved by the Lille Pasteur Institute ethical committee and carried out in agreement with European Union (EEC no. 07430) and French ethical guidelines.</p></div></div><div id="__sec25" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec25title">Author contribution</h2><p id="__p54" class="p p-first-last">PL analyzed genomic data. CG, BD, and HD performed microarray analysis, FL, MP, EB, and NH performed in vivo experiments and associated biochemical analysis. JV performed histological analysis of mouse livers. FPZ, EW, and MBG performed in vitro experiments. AD, GH, LV, WJK, PM, and TV collected human biopsies and histological and biochemical data. CM and JE contributed to genomic analysis. LVG, AV, and SF supervised human biopsies collection and analysis. PL, SF, and BS conceived the study, interpreted data, and wrote the manuscript, and they share the corresponding authorship. SF and BS share the senior authorship.</p></div><div id="sd" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sdtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><!--caption a9--><strong>Supplemental Table 1:</strong><div class="sup-box half_rhythm" id="d35e1873"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s001.xlsx">Click here to view.</a><sup>(222K, xlsx)</sup></div></div><div class="sec suppmat" id="SD2"><!--caption a9--><strong>Supplemental Table 2:</strong><div class="sup-box half_rhythm" id="d35e1878"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s006.xlsx">Click here to view.</a><sup>(41K, xlsx)</sup></div></div><div class="sec suppmat" id="SD3"><!--caption a9--><strong>Supplemental Table 3:</strong><div class="sup-box half_rhythm" id="d35e1883"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s007.xlsx">Click here to view.</a><sup>(14K, xlsx)</sup></div></div><div class="sec suppmat" id="SD4"><!--caption a9--><strong>Supplemental Table 4:</strong><div class="sup-box half_rhythm" id="d35e1888"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s008.xlsx">Click here to view.</a><sup>(211K, xlsx)</sup></div></div><div class="sec suppmat" id="SD5"><!--caption a9--><strong>Supplemental Table 5:</strong><div class="sup-box half_rhythm" id="d35e1893"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s009.xlsx">Click here to view.</a><sup>(172K, xlsx)</sup></div></div><div class="sec suppmat" id="SD6"><!--caption a9--><strong>Supplemental Table 6:</strong><div class="sup-box half_rhythm" id="d35e1898"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s010.xlsx">Click here to view.</a><sup>(142K, xlsx)</sup></div></div><div class="sec suppmat" id="SD7"><!--caption a9--><strong>Supplemental Table 7:</strong><div class="sup-box half_rhythm" id="d35e1903"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s011.xlsx">Click here to view.</a><sup>(53K, xlsx)</sup></div></div><div class="sec suppmat" id="SD8"><!--caption a9--><strong>Supplemental Table 8:</strong><div class="sup-box half_rhythm" id="d35e1908"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s012.xlsx">Click here to view.</a><sup>(395K, xlsx)</sup></div></div><div class="sec suppmat" id="SD9"><!--caption a9--><strong>Supplemental Table 9:</strong><div class="sup-box half_rhythm" id="d35e1913"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s013.xlsx">Click here to view.</a><sup>(175K, xlsx)</sup></div></div><div class="sec suppmat" id="SD10"><!--caption a9--><strong>Supplemental Table 10:</strong><div class="sup-box half_rhythm" id="d35e1918"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s002.xlsx">Click here to view.</a><sup>(200K, xlsx)</sup></div></div><div class="sec suppmat" id="SD11"><!--caption a9--><strong>Supplemental Table 11:</strong><div class="sup-box half_rhythm" id="d35e1924"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s003.xlsx">Click here to view.</a><sup>(35K, xlsx)</sup></div></div><div class="sec suppmat" id="SD12"><!--caption a9--><strong>Supplemental Table 12:</strong><div class="sup-box half_rhythm" id="d35e1929"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s004.xlsx">Click here to view.</a><sup>(13K, xlsx)</sup></div></div><div class="sec suppmat" id="SD13"><!--caption a9--><strong>Supplemental Table 13:</strong><div class="sup-box half_rhythm" id="d35e1934"><a href="/pmc/articles/PMC5499370/bin/jciinsight-2-92264-s005.xlsx">Click here to view.</a><sup>(46K, xlsx)</sup></div></div></div><div id="idm140116555226144" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140116555226144title">Acknowledgments</h2><div class="sec"><p id="__p55">We thank Julie Dubois-Chevalier for help with ChIP-Seq data analysis. This study was supported by grants from the European Union (FP6 Hepadip FP6-018734 and FP7 Resolve, FP7-305707), Fondation de France (grant 2014 00047965), Fondation pour la Recherche M&#x000e9;dicale (Equipe labellis&#x000e9;e, DEQ20150331724), and Agence Nationale pour la Recherche (ANR-10-LBEX-46). MP is supported by Foundation for Polish Science and National Science Centre, Poland (2014/15/D/NZ5/03421).</p></div></div><div id="idm140116555224880" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140116555224880title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140116555224752"><p id="__p56" class="p p-first-last">MP&#x02019;s current address is: International Institute of Molecular and Cell Biology, Warsaw, Poland.</p></p><p class="fn sec" id="idm140116555223952"><p id="__p57" class="p p-first-last"><strong>Conflict of interest:</strong> BS and SF are consultants for Genfit SA.</p></p><p class="fn sec" id="idm140116555222736"><p id="__p58" class="p p-first-last"><strong>Reference information:</strong><em> JCI Insight</em>. 2017;2(13):e92264. https://doi.org/10.1172/jci.insight.92264.</p></p></div></div><div id="idm140116555221392" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140116555221392title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Byrne CD, Targher G. NAFLD: a multisystem disease. <span><span class="ref-journal">J Hepatol. </span>2015;<span class="ref-vol">62</span>(1 Suppl):S47–S64.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25920090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Satapathy SK, Sanyal AJ. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. <span><span class="ref-journal">Semin Liver Dis. </span>2015;<span class="ref-vol">35</span>(3):221–235. doi: 10.1055/s-0035-1562943.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26378640" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1055%2Fs-0035-1562943" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Ekstedt M, et al.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. <span><span class="ref-journal">Hepatology. </span>2015;<span class="ref-vol">61</span>(5):1547–1554. doi: 10.1002/hep.27368.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25125077" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.27368" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. <span><span class="ref-journal">J Hepatol. </span>2012;<span class="ref-vol">56</span>(5):1171–1180. doi: 10.1016/j.jhep.2011.09.024.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22245903" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2011.09.024" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Karsdal MA, et al.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2015;<span class="ref-vol">308</span>(10):G807–G830. doi: 10.1152/ajpgi.00447.2014.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4437019/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25767261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1152%2Fajpgi.00447.2014" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. <span><span class="ref-journal">Dis Model Mech. </span>2011;<span class="ref-vol">4</span>(2):165–178. doi: 10.1242/dmm.004077.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3046088/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21324931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1242%2Fdmm.004077" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Mannaerts I, et al.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. <span><span class="ref-journal">J Hepatol. </span>2015;<span class="ref-vol">63</span>(3):679–688. doi: 10.1016/j.jhep.2015.04.011.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25908270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2015.04.011" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Marrone G, Shah VH, Gracia-Sancho J. Sinusoidal communication in liver fibrosis and regeneration. <span><span class="ref-journal">J Hepatol. </span>2016;<span class="ref-vol">65</span>(3):608–617. doi: 10.1016/j.jhep.2016.04.018.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4992446/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/27151183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2016.04.018" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. <span><span class="ref-journal">Gut. </span>2015;<span class="ref-vol">64</span>(5):830–841. doi: 10.1136/gutjnl-2014-306842.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4477794/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25681399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1136%2Fgutjnl-2014-306842" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Adams LA, et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. <span><span class="ref-journal">Gastroenterology. </span>2005;<span class="ref-vol">129</span>(1):113–121. doi: 10.1053/j.gastro.2005.04.014.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16012941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2005.04.014" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. <span><span class="ref-journal">Gastroenterology. </span>1999;<span class="ref-vol">116</span>(6):1413–1419. doi: 10.1016/S0016-5085(99)70506-8.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10348825" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2FS0016-5085(99)70506-8" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Vilar-Gomez E, et al.  Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">149</span>(2):367–378.e5. doi: 10.1053/j.gastro.2015.04.005.</span> ; quiz e14.  <span class="nowrap ref pubmed">[<a href="/pubmed/25865049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2015.04.005" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Dixon JB, Bhathal PS, Hughes NR, O&#x02019;Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. <span><span class="ref-journal">Hepatology. </span>2004;<span class="ref-vol">39</span>(6):1647–1654. doi: 10.1002/hep.20251.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15185306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.20251" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. <span><span class="ref-journal">Diabetes. </span>2005;<span class="ref-vol">54</span>(3):603–608. doi: 10.2337/diabetes.54.3.603.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2995496/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15734833" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdiabetes.54.3.603" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Mathurin P, et al.  Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">137</span>(2):532–540. doi: 10.1053/j.gastro.2009.04.052.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19409898" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2009.04.052" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Lassailly G, et al.  Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">149</span>(2):379–388.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25917783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Sasaki A, et al.  Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. <span><span class="ref-journal">Front Endocrinol (Lausanne) </span>2014;<span class="ref-vol">5</span>:164</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4209858/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25386164" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPAR&#x003b1; action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. <span><span class="ref-journal">J Hepatol. </span>2015;<span class="ref-vol">62</span>(3):720–733. doi: 10.1016/j.jhep.2014.10.039.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25450203" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2014.10.039" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Dubois V, Eeckhoute J, Lefebvre P, Staels B. Distinct but complementary contributions of PPAR isotypes to energy homeostasis. <span><span class="ref-journal">J Clin Invest. </span>2017;<span class="ref-vol">127</span>(4):1202–1214. doi: 10.1172/JCI88894.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC5373878/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/28368286" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1172%2FJCI88894" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2013;<span class="ref-vol">10</span>(11):627–636. doi: 10.1038/nrgastro.2013.149.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23958599" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fnrgastro.2013.149" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Haas JT, Francque S, Staels B. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. <span><span class="ref-journal">Annu Rev Physiol. </span>2016;<span class="ref-vol">78</span>:181–205. doi: 10.1146/annurev-physiol-021115-105331.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26667070" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1146%2Fannurev-physiol-021115-105331" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Starmann J, et al.  Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>(10):e46584 doi: 10.1371/journal.pone.0046584.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3468618/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23071592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1371%2Fjournal.pone.0046584" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Yoneda M, et al.  Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis. <span><span class="ref-journal">Hepatol Res. </span>2008;<span class="ref-vol">38</span>(12):1204–1212.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18637145" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Arendt BM, et al.  Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. <span><span class="ref-journal">Hepatology. </span>2015;<span class="ref-vol">61</span>(5):1565–1578. doi: 10.1002/hep.27695.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25581263" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.27695" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Clarke JD, et al.  Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. <span><span class="ref-journal">Dig Dis Sci. </span>2014;<span class="ref-vol">59</span>(2):365–374. doi: 10.1007/s10620-013-2873-9.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3945102/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24048683" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2Fs10620-013-2873-9" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Lake AD, et al.  Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. <span><span class="ref-journal">Drug Metab Dispos. </span>2011;<span class="ref-vol">39</span>(10):1954–1960. doi: 10.1124/dmd.111.040592.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3186211/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21737566" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1124%2Fdmd.111.040592" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Moylan CA, et al.  Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">59</span>(2):471–482. doi: 10.1002/hep.26661.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3982589/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23913408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.26661" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Murphy SK, et al.  Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. <span><span class="ref-journal">Gastroenterology. </span>2013;<span class="ref-vol">145</span>(5):1076–1087. doi: 10.1053/j.gastro.2013.07.047.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3805742/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23916847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2013.07.047" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Dudley JT, Tibshirani R, Deshpande T, Butte AJ. Disease signatures are robust across tissues and experiments. <span><span class="ref-journal">Mol Syst Biol. </span>2009;<span class="ref-vol">5</span>:307</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2758720/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19756046" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Takeda U, et al.  Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. <span><span class="ref-journal">J Invest Dermatol. </span>2002;<span class="ref-vol">119</span>(3):678–683. doi: 10.1046/j.1523-1747.2002.01863.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12230512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1046%2Fj.1523-1747.2002.01863.x" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Wu W, et al.  Dermatopontin regulates fibrin formation and its biological activity. <span><span class="ref-journal">J Invest Dermatol. </span>2014;<span class="ref-vol">134</span>(1):256–263. doi: 10.1038/jid.2013.305.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23877568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fjid.2013.305" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Wu W, et al.  Functional peptide of dermatopontin produces fibrinogen fibrils and modifies its biological activity. <span><span class="ref-journal">J Dermatol Sci. </span>2014;<span class="ref-vol">76</span>(1):34–43. doi: 10.1016/j.jdermsci.2014.07.002.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25082449" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jdermsci.2014.07.002" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Kato A, et al.  Identification of fibronectin binding sites in dermatopontin and their biological function. <span><span class="ref-journal">J Dermatol Sci. </span>2014;<span class="ref-vol">76</span>(1):51–59. doi: 10.1016/j.jdermsci.2014.07.003.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25092262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jdermsci.2014.07.003" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Okamoto O, Fujiwara S, Abe M, Sato Y. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. <span><span class="ref-journal">Biochem J. </span>1999;<span class="ref-vol">337</span>(Pt 3):537–541.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1220007/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9895299" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Francque S, et al.  PPAR&#x003b1; gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. <span><span class="ref-journal">J Hepatol. </span>2015;<span class="ref-vol">63</span>(1):164–173. doi: 10.1016/j.jhep.2015.02.019.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25703085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2015.02.019" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Pawlak M, et al.  The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">60</span>(5):1593–1606. doi: 10.1002/hep.27297.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24995693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.27297" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. <span><span class="ref-journal">Histopathology. </span>2012;<span class="ref-vol">61</span>(2):141–152. doi: 10.1111/j.1365-2559.2011.04145.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22372457" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1365-2559.2011.04145.x" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. <span><span class="ref-journal">World J Gastroenterol. </span>2012;<span class="ref-vol">18</span>(19):2300–2308. doi: 10.3748/wjg.v18.i19.2300.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3353364/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22654421" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3748%2Fwjg.v18.i19.2300" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. <span><span class="ref-journal">Toxicol Appl Pharmacol. </span>1998;<span class="ref-vol">153</span>(1):109–118. doi: 10.1006/taap.1998.8547.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9875305" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1006%2Ftaap.1998.8547" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Braeuning A, et al.  Differential gene expression in periportal and perivenous mouse hepatocytes. <span><span class="ref-journal">FEBS J. </span>2006;<span class="ref-vol">273</span>(22):5051–5061. doi: 10.1111/j.1742-4658.2006.05503.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17054714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1742-4658.2006.05503.x" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. <span><span class="ref-journal">Hepatology. </span>2015;<span class="ref-vol">61</span>(3):1066–1079. doi: 10.1002/hep.27332.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4306641/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25066777" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.27332" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Azimifar SB, Nagaraj N, Cox J, Mann M. Cell-type-resolved quantitative proteomics of murine liver. <span><span class="ref-journal">Cell Metab. </span>2014;<span class="ref-vol">20</span>(6):1076–1087. doi: 10.1016/j.cmet.2014.11.002.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25470552" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.cmet.2014.11.002" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Ding C, et al.  A Cell-type-resolved Liver Proteome. <span><span class="ref-journal">Mol Cell Proteomics. </span>2016;<span class="ref-vol">15</span>(10):3190–3202. doi: 10.1074/mcp.M116.060145.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC5054343/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/27562671" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1074%2Fmcp.M116.060145" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Milani S, et al.  Undulin RNA and protein expression in normal and fibrotic human liver. <span><span class="ref-journal">Hepatology. </span>1994;<span class="ref-vol">20</span>(4 Pt 1):908–916.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7523266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Arriazu E, et al.  Extracellular matrix and liver disease. <span><span class="ref-journal">Antioxid Redox Signal. </span>2014;<span class="ref-vol">21</span>(7):1078–1097. doi: 10.1089/ars.2013.5697.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4123471/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24219114" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1089%2Fars.2013.5697" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Neill T, Schaefer L, Iozzo RV. Instructive roles of extracellular matrix on autophagy. <span><span class="ref-journal">Am J Pathol. </span>2014;<span class="ref-vol">184</span>(8):2146–2153. doi: 10.1016/j.ajpath.2014.05.010.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4116694/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24976620" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.ajpath.2014.05.010" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="element-citation">Krishnan A, et al.  Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. <span><span class="ref-journal">Lab Invest. </span>2012;<span class="ref-vol">92</span>(12):1712–1725. doi: 10.1038/labinvest.2012.121.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3810270/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23007134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Flabinvest.2012.121" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="element-citation">Kato A, et al.  Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>(17):14861–14869. doi: 10.1074/jbc.M110.179762.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3083196/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21398523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1074%2Fjbc.M110.179762" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="element-citation">Mederacke I, et al.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. <span><span class="ref-journal">Nat Commun. </span>2013;<span class="ref-vol">4</span>:2823</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4059406/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24264436" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="element-citation">Huang G, Brigstock DR. Regulation of hepatic stellate cells by connective tissue growth factor. <span><span class="ref-journal">Front Biosci (Landmark Ed) </span>2012;<span class="ref-vol">17</span>:2495–2507. doi: 10.2741/4067.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22652794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2741%2F4067" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="element-citation">Fujii T, et al.  Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. <span><span class="ref-journal">BMC Gastroenterol. </span>2010;<span class="ref-vol">10</span>:79</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2912240/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20618941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="element-citation">Xu MJ, et al.  Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">149</span>(4):1030–41.e6. doi: 10.1053/j.gastro.2015.06.009.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4584194/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26099526" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2015.06.009" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="element-citation">Seifert L, et al.  Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways. <span><span class="ref-journal">Cell Rep. </span>2015;<span class="ref-vol">13</span>(9):1909–1921. doi: 10.1016/j.celrep.2015.10.058.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4681001/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26655905" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.celrep.2015.10.058" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="element-citation">Mor&#x000e1;n-Salvador E, et al.  Cell-specific PPAR&#x003b3; deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. <span><span class="ref-journal">J Hepatol. </span>2013;<span class="ref-vol">59</span>(5):1045–1053. doi: 10.1016/j.jhep.2013.06.023.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23831119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jhep.2013.06.023" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="element-citation">Liu Y, et al.  Transforming growth factor-&#x003b2; (TGF-&#x003b2;)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. <span><span class="ref-journal">J Biol Chem. </span>2013;<span class="ref-vol">288</span>(42):30708–30719. doi: 10.1074/jbc.M113.478685.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3798541/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24005672" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1074%2Fjbc.M113.478685" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="element-citation">Dattaroy D, et al.  Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2015;<span class="ref-vol">308</span>(4):G298–G312. doi: 10.1152/ajpgi.00346.2014.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4329476/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25501551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1152%2Fajpgi.00346.2014" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="element-citation">Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. <span><span class="ref-journal">Protein Cell. </span>2012;<span class="ref-vol">3</span>(5):364–371. doi: 10.1007/s13238-012-2036-3.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4875471/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22610888" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2Fs13238-012-2036-3" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="element-citation">Okamoto O, Suzuki Y, Kimura S, Shinkai H. Extracellular matrix 22-kDa protein interacts with decorin core protein and is expressed in cutaneous fibrosis. <span><span class="ref-journal">J Biochem. </span>1996;<span class="ref-vol">119</span>(1):106–114. doi: 10.1093/oxfordjournals.jbchem.a021194.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8907183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1093%2Foxfordjournals.jbchem.a021194" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="element-citation">Staels B, et al.  Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. <span><span class="ref-journal">Hepatology. </span>2013;<span class="ref-vol">58</span>(6):1941–1952. doi: 10.1002/hep.26461.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23703580" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.26461" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60">60. <span class="element-citation">Ratziu V, et al.  Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-&#x003b1; and -&#x003b4;, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. <span><span class="ref-journal">Gastroenterology. </span>2016;<span class="ref-vol">150</span>(5):1147–1159.e5. doi: 10.1053/j.gastro.2016.01.038.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26874076" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2016.01.038" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61">61. <span class="element-citation">Machado MV, et al.  Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>(5):e0127991 doi: 10.1371/journal.pone.0127991.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4446215/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26017539" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1371%2Fjournal.pone.0127991" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62">62. <span class="element-citation">Ramadoss P, Chiappini F, Bilban M, Hollenberg AN. Regulation of hepatic six transmembrane epithelial antigen of prostate 4 (STEAP4) expression by STAT3 and CCAAT/enhancer-binding protein alpha. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>(22):16453–16466. doi: 10.1074/jbc.M109.066936.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2878015/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20304921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1074%2Fjbc.M109.066936" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63">63. <span class="element-citation">Wright JH, et al.  Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. <span><span class="ref-journal">Int J Cancer. </span>2014;<span class="ref-vol">134</span>(4):778–788. doi: 10.1002/ijc.28421.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3876966/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23929039" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fijc.28421" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64">64. <span class="element-citation">Lee JI, et al.  Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis. <span><span class="ref-journal">Am J Physiol, Cell Physiol. </span>2016;<span class="ref-vol">310</span>(6):C436–C445. doi: 10.1152/ajpcell.00423.2014.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4796282/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26632601" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1152%2Fajpcell.00423.2014" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65">65. <span class="element-citation">Kintscher U, et al.  PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. <span><span class="ref-journal">Circ Res. </span>2002;<span class="ref-vol">91</span>(11):e35–e44. doi: 10.1161/01.RES.0000046017.96083.34.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12456495" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1161%2F01.RES.0000046017.96083.34" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66">66. <span class="element-citation">St&#x000e4;rkel P, et al.  Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. <span><span class="ref-journal">J Hepatol. </span>2003;<span class="ref-vol">39</span>(4):538–546. doi: 10.1016/S0168-8278(03)00360-X.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12971963" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2FS0168-8278(03)00360-X" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B67">67. <span class="element-citation">Kim Y, et al.  Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>(50):33750–33758. doi: 10.1074/jbc.273.50.33750.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9837963" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1074%2Fjbc.273.50.33750" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B68">68. <span class="element-citation">Baker SS, Baker RD, Liu W, Nowak NJ, Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>(3):e9570 doi: 10.1371/journal.pone.0009570.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2833196/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20221393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1371%2Fjournal.pone.0009570" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B69">69. <span class="element-citation">Teufel A, et al.  Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. <span><span class="ref-journal">Gastroenterology. </span>2016;<span class="ref-vol">151</span>(3):513–525.e0. doi: 10.1053/j.gastro.2016.05.051.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/27318147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1053%2Fj.gastro.2016.05.051" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B70">70. <span class="element-citation">Tracy LE, Minasian RA, Caterson EJ. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. <span><span class="ref-journal">Adv Wound Care (New Rochelle) </span>2016;<span class="ref-vol">5</span>(3):119–136. doi: 10.1089/wound.2014.0561.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4779293/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26989578" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1089%2Fwound.2014.0561" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B71">71. <span class="element-citation">Okamoto O, Fujiwara S. Dermatopontin, a novel player in the biology of the extracellular matrix. <span><span class="ref-journal">Connect Tissue Res. </span>2006;<span class="ref-vol">47</span>(4):177–189. doi: 10.1080/03008200600846564.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16987749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1080%2F03008200600846564" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B72">72. <span class="element-citation">Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. <span><span class="ref-journal">FASEB J. </span>1992;<span class="ref-vol">6</span>(2):724–730.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/1537462" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B73">73. <span class="element-citation">Fu Y, et al.  DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by &#x003b1;3&#x003b2;1 integrin-Rho GTPase signaling. <span><span class="ref-journal">Oncotarget. </span>2014;<span class="ref-vol">5</span>(16):6701–6715. doi: 10.18632/oncotarget.2239.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4196157/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25149533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.18632%2Foncotarget.2239" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B74">74. <span class="element-citation">Pochampally RR, Ylostalo J, Penfornis P, Matz RR, Smith JR, Prockop DJ. Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor. <span><span class="ref-journal">J Bone Miner Res. </span>2007;<span class="ref-vol">22</span>(9):1338–1349. doi: 10.1359/jbmr.070605.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17547532" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1359%2Fjbmr.070605" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B75">75. <span class="element-citation">Derfoul A, Perkins GL, Hall DJ, Tuan RS. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. <span><span class="ref-journal">Stem Cells. </span>2006;<span class="ref-vol">24</span>(6):1487–1495. doi: 10.1634/stemcells.2005-0415.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16469821" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1634%2Fstemcells.2005-0415" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B76">76. <span class="element-citation">Verrijken A, et al.  Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">59</span>(1):121–129. doi: 10.1002/hep.26510.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24375485" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fhep.26510" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B77">77. <span class="element-citation">Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. <span><span class="ref-journal">Nat Protoc. </span>2008;<span class="ref-vol">3</span>(6):1101–1108. doi: 10.1038/nprot.2008.73.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18546601" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fnprot.2008.73" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B78">78. <span class="element-citation">Dennis G, et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery. <span><span class="ref-journal">Genome Biol. </span>2003;<span class="ref-vol">4</span>(5):P3 doi: 10.1186/gb-2003-4-5-p3.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12734009" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2Fgb-2003-4-5-p3" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B79">79. <span class="element-citation">Tripathi S, et al.  Meta- and Orthogonal Integration of Influenza &#x0201c;OMICs&#x0201d; Data Defines a Role for UBR4 in Virus Budding. <span><span class="ref-journal">Cell Host Microbe. </span>2015;<span class="ref-vol">18</span>(6):723–735. doi: 10.1016/j.chom.2015.11.002.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4829074/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26651948" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.chom.2015.11.002" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B80">80. <span class="element-citation">Kita Y, et al.  Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>(9):e43056 doi: 10.1371/journal.pone.0043056.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3445596/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23028442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1371%2Fjournal.pone.0043056" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B81">81. <span class="element-citation">Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. <span><span class="ref-journal">Behav Res Methods. </span>2009;<span class="ref-vol">41</span>(4):1149–1160. doi: 10.3758/BRM.41.4.1149.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19897823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3758%2FBRM.41.4.1149" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B82">82. <span class="element-citation">Chen EY, et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. <span><span class="ref-journal">BMC Bioinformatics. </span>2013;<span class="ref-vol">14</span>:128</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3637064/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23586463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B83">83. <span class="element-citation">Kuleshov MV, et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. <span><span class="ref-journal">Nucleic Acids Res. </span>2016;<span class="ref-vol">44</span>(W1):W90–W97. doi: 10.1093/nar/gkw377.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4987924/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/27141961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1093%2Fnar%2Fgkw377" target="pmc_ext" ref="reftype=other&amp;article-id=5499370&amp;issue-id=294930&amp;journal-id=3101&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">JCI Insight</span> are provided here courtesy of <strong>American Society for Clinical Investigation</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5499370/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5499370/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5499370/pdf/jciinsight-2-92264.pdf">PDF (1.8M)</a></li> | <li><a href="#" data-citationid="PMC5499370" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5499370%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5499370%2F&amp;text=Interspecies%20NASH%20disease%20activity%20whole-genome%20profiling%20identifies%20a%20fibrogenic%20role%20of%20PPAR%CE%B1-regulated%20dermatopontin"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5499370%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="28679947" data-aiid="5499370" data-aid="5499370" data-iid="294930" data-domainid="3101" data-domain="jciinsight" data-accid="PMC5499370" data-md5="208ad1bff8f1692c0f2b23e75a301a97"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T20:35:46-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc201&amp;ncbi_phid=F4FB49BFB4D38EC10000000000820081&amp;ncbi_session=F4FB49BFB4D39E11_0130SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5499370%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jciinsight&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5499370/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FB49BFB4D39E11_0130SID /projects/PMC/PMCViewer@4.46 ptpmc201 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>